2024/06/26 更新

写真a

カサイ アツシ
笠井 淳司
KASAI Atsushi
所属
環境医学研究所 ストレス受容・応答研究部門 教授
大学院担当
大学院医学系研究科
職名
教授
外部リンク

学位 1

  1. 博士(薬学) ( 2007年3月   大阪大学 ) 

研究キーワード 13

  1. 精神疾患

  2. 発達障害

  3. 前障

  4. 不安

  5. ストレス

  6. イメージング

  7. 社会性行動

  8. 不公平嫌悪

  9. 前障

  10. 精神疾患

  11. 全脳イメージング

  12. ストレス

  13. 情動

研究分野 2

  1. ライフサイエンス / 神経科学一般

  2. ライフサイエンス / 薬理学

経歴 7

  1. 名古屋大学   環境医学研究所 ストレス受容・応答研究部門   教授

    2024年4月 - 現在

  2. 大阪大学   大学院薬学研究科   准教授

    2020年6月 - 2024年3月

  3. 大阪大学   大学院薬学研究科   講師

    2020年4月 - 2020年6月

  4. 大阪大学   大学院薬学研究科   助教

    2014年9月 - 2020年3月

  5. 大阪大学   未来戦略機構   特任助教

    2012年5月 - 2014年9月

  6. カリフォルニア大学ロサンゼルス校   博士研究員

    2011年4月 - 2012年4月

  7. 摂南大学   薬学部   助教

    2007年4月 - 2011年3月

▼全件表示

学歴 2

  1. 大阪大学   大学院薬学研究科

    2002年4月 - 2007年3月

  2. 静岡県立大学   薬学部

    1997年4月 - 2002年3月

所属学協会 5

  1. 日本薬理学会

      詳細を見る

  2. 日本薬学会

      詳細を見る

  3. 日本精神神経薬理学会

      詳細を見る

  4. 日本神経化学会

      詳細を見る

  5. 北米神経科学会

      詳細を見る

委員歴 2

  1. 日本神経化学会   評議委員  

    2019年5月   

      詳細を見る

    団体区分:学協会

    researchmap

  2. 日本薬理学会   代議員  

    2012年 - 現在   

      詳細を見る

    団体区分:学協会

    researchmap

受賞 7

  1. 日本薬学会薬理系薬学部会奨励賞

    2022年8月   日本薬学会  

  2. 日本神経化学会優秀賞

    2022年7月   日本神経化学会  

     詳細を見る

    受賞区分:国内学会・会議・シンポジウム等の賞 

  3. 第10回武田科学振興財団 薬科学シンポジウム Excellent Poster Award

    2020年1月   武田科学振興財団  

    笠井淳司

     詳細を見る

  4. 平成26年度 包括脳ネットワーク 冬のシンポジウム 若手優秀発表賞

    2014年12月   包括型脳科学研究推進支援ネットワーク  

    笠井 淳司

     詳細を見る

  5. 大阪大学総長奨励賞

    2014年7月   大阪大学  

  6. 日本薬学会近畿支部奨励賞

    2011年7月   日本薬学会  

    笠井 淳司

     詳細を見る

  7. 日本血管生物医学会Young Investigator Award

    2010年12月   日本血管生物医学会  

▼全件表示

 

論文 71

  1. (R)-ketamine restores anterior insular cortex activity and cognitive deficits in social isolation-reared mice 査読有り 国際誌

    Yokoyama, R; Ago, Y; Igarashi, H; Higuchi, M; Tanuma, M; Shimazaki, Y; Kawai, T; Seiriki, K; Hayashida, M; Yamaguchi, S; Tanaka, H; Nakazawa, T; Okamura, Y; Hashimoto, K; Kasai, A; Hashimoto, H

    MOLECULAR PSYCHIATRY     2024年2月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Molecular Psychiatry  

    Chronic social isolation increases the risk of mental health problems, including cognitive impairments and depression. While subanesthetic ketamine is considered effective for cognitive impairments in patients with depression, the neural mechanisms underlying its effects are not well understood. Here we identified unique activation of the anterior insular cortex (aIC) as a characteristic feature in brain-wide regions of mice reared in social isolation and treated with (R)-ketamine, a ketamine enantiomer. Using fiber photometry recording on freely moving mice, we found that social isolation attenuates aIC neuronal activation upon social contact and that (R)-ketamine, but not (S)-ketamine, is able to counteracts this reduction. (R)-ketamine facilitated social cognition in social isolation-reared mice during the social memory test. aIC inactivation offset the effect of (R)-ketamine on social memory. Our results suggest that (R)-ketamine has promising potential as an effective intervention for social cognitive deficits by restoring aIC function.

    DOI: 10.1038/s41380-024-02419-6

    Web of Science

    Scopus

    PubMed

    researchmap

  2. Molecular basis of astrocyte diversity and morphology across the CNS in health and disease 査読有り 国際誌

    Endo, F; Kasai, A; Soto, JS; Yu, XZ; Qu, Z; Hashimoto, H; Gradinaru, V; Kawaguchi, R; Khakh, BS

    SCIENCE   378 巻 ( 6619 ) 頁: 514 - +   2022年11月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Science  

    Astrocytes, a type of glia, are abundant and morphologically complex cells. Here, we report astrocyte molecular profiles, diversity, and morphology across the mouse central nervous system (CNS). We identified shared and region-specific astrocytic genes and functions and explored the cellular origins of their regional diversity. We identified gene networks correlated with astrocyte morphology, several of which unexpectedly contained Alzheimer's disease (AD) risk genes. CRISPR/Cas9-mediated reduction of candidate genes reduced astrocyte morphological complexity and resulted in cognitive deficits. The same genes were down-regulated in human AD, in an AD mouse model that displayed reduced astrocyte morphology, and in other human brain disorders. We thus provide comprehensive molecular data on astrocyte diversity and mechanisms across the CNS and on the molecular basis of astrocyte morphology in health and disease.

    DOI: 10.1126/science.adc9020

    Web of Science

    Scopus

    PubMed

    researchmap

  3. Claustrum mediates bidirectional and reversible control of stress-induced anxiety responses 査読有り 国際誌

    Niu, M; Kasai, A; Tanuma, M; Seiriki, K; Igarashi, H; Kuwaki, T; Nagayasu, K; Miyaji, K; Ueno, H; Tanabe, W; Seo, K; Yokoyama, R; Ohkubo, J; Ago, Y; Hayashida, M; Inoue, KI; Takada, M; Yamaguchi, S; Nakazawa, T; Kaneko, S; Okuno, H; Yamanaka, A; Hashimoto, H

    SCIENCE ADVANCES   8 巻 ( 11 ) 頁: eabi6375   2022年3月

     詳細を見る

    担当区分:筆頭著者, 責任著者   記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Science Advances  

    The processing of stress responses involves brain-wide communication among cortical and subcortical regions; however, the underlying mechanisms remain elusive. Here, we show that the claustrum (CLA) is crucial for the control of stress-induced anxiety-related behaviors. A combined approach using brain activation mapping and machine learning showed that the CLA activation serves as a reliable marker of exposure to acute stressors. In TRAP2 mice, which allow activity-dependent genetic labeling, chemogenetic activation of the CLA neuronal ensemble tagged by acute social defeat stress (DS) elicited anxiety-related behaviors, whereas silencing of the CLA ensemble attenuated DS-induced anxiety-related behaviors. Moreover, the CLA received strong input from DS-activated basolateral amygdala neurons, and its circuit-selective optogenetic photostimulation temporarily elicited anxiety-related behaviors. Last, silencing of the CLA ensemble during stress exposure increased resistance to chronic DS. The CLA thus bidirectionally controls stress-induced emotional responses, and its inactivation can serve as a preventative strategy to increase stress resilience.

    DOI: 10.1126/sciadv.abi6375

    Web of Science

    Scopus

    PubMed

    researchmap

  4. Direct visualization of an antidepressant analog using surface-enhanced Raman scattering in the brain 査読有り

    Tanuma, M; Kasai, A; Bando, K; Kotoku, N; Harada, K; Minoshima, M; Higashino, K; Kimishima, A; Arai, M; Ago, Y; Seiriki, K; Kikuchi, K; Kawata, S; Fujita, K; Hashimoto, H

    JCI INSIGHT   5 巻 ( 6 )   2020年3月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:JCI Insight  

    Detailed spatial information of low-molecular weight compound distribution, especially in the brain, is crucial to understanding their mechanism of actions. Imaging techniques that can directly visualize drugs in the brain at a high resolution will complement existing tools for drug distribution analysis. Here, we performed surface-enhanced Raman scattering (SERS) imaging using a bioorthogonal alkyne tag to visualize drugs directly in situ at a high resolution. Focusing on the selective serotonin reuptake inhibitor S-citalopram (S-Cit), which possesses a nitrile group, we substituted an alkynyl group into its structure and synthesized alkynylated S-Cit (Alk-S-Cit). The brain transitivity and the serotonin reuptake inhibition of Alk-S-Cit were not significantly different as compared with S-Cit. Alk-S-Cit was visualized in the coronal mouse brain section using SERS imaging with silver nanoparticles. Furthermore, SERS imaging combined with fluorescence microscopy allowed Alk-S-Cit to be visualized in the adjacent neuronal membranes, as well as in the brain vessel and parenchyma. Therefore, our multimodal imaging technique is an effective method for detecting low-molecular weight compounds in their original tissue environment and can potentially offer additional information regarding the precise spatial distribution of such drugs.

    DOI: 10.1172/jci.insight.133348

    Web of Science

    Scopus

    PubMed

    researchmap

  5. Whole-brain block-face serial microscopy tomography at subcellular resolution using FAST 査読有り 国際誌

    Seiriki, K; Kasai, A; Nakazawa, T; Niu, M; Naka, Y; Tanuma, M; Igarashi, H; Yamaura, K; Hayata-Takano, A; Ago, Y; Hashimoto, H

    NATURE PROTOCOLS   14 巻 ( 5 ) 頁: 1509 - 1529   2019年5月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Nature Protocols  

    Here, we describe an optimized and detailed protocol for block-face serial microscopy tomography (FAST). FAST enables high-speed serial section fluorescence imaging of fixed brains at an axonal spatial resolution and subsequent image data processing. It renders brain-wide anatomical and functional analyses, including structural profiling of nuclear-stained brain at the single-cell level, cell-type-specific mapping with reporter animal brains and neuronal tracing with anterograde/retrograde labeling. Light-sheet fluorescence microscopy of cleared brains is advantageous in regard to imaging speed, but its spatial resolution is generally limited, whereas the opposite is true for conventional confocal microscopy. FAST offers a solution to overcome these technical limitations. This protocol describes detailed procedures for assembling the FAST hardware, sample preparation, imaging and image processing. A single imaging session takes as little as 2.4 h per mouse brain, and sample preparation requires 1 to several days, depending on pretreatments; however, multiple samples can be prepared simultaneously. We anticipate that FAST will contribute to unbiased and hypothesis-free approaches for a better understanding of brain systems.

    DOI: 10.1038/s41596-019-0148-4

    Web of Science

    Scopus

    PubMed

    researchmap

  6. High-Speed and Scalable Whole-Brain Imaging in Rodents and Primates 査読有り

    Seiriki, K; Kasai, A; Hashimoto, T; Schulze, W; Niu, M; Yamaguchi, S; Nakazawa, T; Inoue, KI; Uezono, S; Takada, M; Naka, Y; Igarashi, H; Tanuma, M; Waschek, JA; Ago, Y; Tanaka, KF; Hayata-Takano, A; Nagayasu, K; Shintani, N; Hashimoto, R; Kunii, Y; Hino, M; Matsumoto, J; Yabe, H; Nagai, T; Fujita, K; Matsuda, T; Takuma, K; Baba, A; Hashimoto, H

    NEURON   94 巻 ( 6 ) 頁: 1085 - +   2017年6月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Neuron  

    Subcellular resolution imaging of the whole brain and subsequent image analysis are prerequisites for understanding anatomical and functional brain networks. Here, we have developed a very high-speed serial-sectioning imaging system named FAST (block-face serial microscopy tomography), which acquires high-resolution images of a whole mouse brain in a speed range comparable to that of light-sheet fluorescence microscopy. FAST enables complete visualization of the brain at a resolution sufficient to resolve all cells and their subcellular structures. FAST renders unbiased quantitative group comparisons of normal and disease model brain cells for the whole brain at a high spatial resolution. Furthermore, FAST is highly scalable to non-human primate brains and human postmortem brain tissues, and can visualize neuronal projections in a whole adult marmoset brain. Thus, FAST provides new opportunities for global approaches that will allow for a better understanding of brain systems in multiple animal models and in human diseases. Seiriki et al. developed a very high-speed serial-sectioning imaging system named FAST that allows whole-brain imaging at a spatial resolution to image all brain cells and long-range neuronal projections in experimental animal models and facilitates animal-to-human translational research.

    DOI: 10.1016/j.neuron.2017.05.017

    Web of Science

    Scopus

    PubMed

    researchmap

  7. Clozapine Induces Neuronal Activation in the Medial Prefrontal Cortex in a Projection Target-Biased Manner 査読有り

    Hirato Y., Seiriki K., Kojima L., Yamada S., Rokujo H., Takemoto T., Nakazawa T., Kasai A., Hashimoto H.

    Biological and Pharmaceutical Bulletin   47 巻 ( 2 ) 頁: 478 - 485   2024年2月

     詳細を見る

    記述言語:英語   出版者・発行元:Biological and Pharmaceutical Bulletin  

    The medial prefrontal cortex (mPFC) is associated with various behavioral controls via diverse projections to cortical and subcortical areas of the brain. Dysfunctions and modulations of this circuitry are related to the pathophysiology of schizophrenia and its pharmacotherapy, respectively. Clozapine is an atypical antipsychotic drug used for treatment-resistant schizophrenia and is known to modulate neuronal activity in the mPFC. However, it remains unclear which prefrontal cortical projections are activated by clozapine among the various projection targets. To identify the anatomical characteristics of neurons activated by clozapine at the mesoscale level, we investigated the brain-wide projection patterns of neurons with clozapine-induced c-Fos expression in the mPFC. Using a whole-brain imaging and virus-mediated genetic tagging of activated neurons, we found that clozapine-responsive neurons in the mPFC had a wide range of projections to the mesolimbic, amygdala and thalamic areas, especially the mediodorsal thalamus. These results may provide key insights into the neuronal basis of the therapeutic action of clozapine.

    DOI: 10.1248/bpb.b23-00835

    Scopus

  8. Long-lasting anti-despair and anti-anhedonia effects of (S)-norketamine in social isolation-reared mice 査読有り

    Yokoyama, R; Higuchi, M; Tanabe, W; Tsukada, S; Igarashi, H; Seiriki, K; Nakazawa, T; Kasai, A; Ago, Y; Hashimoto, H

    JOURNAL OF PHARMACOLOGICAL SCIENCES   154 巻 ( 2 ) 頁: 72 - 76   2024年2月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Journal of Pharmacological Sciences  

    Alternatives to ketamine without psychotomimetic properties for the treatment of depression have attracted much attention. Here, we examined the anti-despair and anti-anhedonia effects of the ketamine metabolites (S)-norketamine ((S)-NK), (R)-NK, (2S,6S)-hydroxynorketamine, and (2R,6R)-hydroxynorketamine in a mouse model of depression induced by social isolation. All ketamine metabolites examined had acute (30 min after administration) anti-despair-like effects in the forced swim test, but only (S)-NK showed a long-lasting (1 week) effect. Additionally, only (S)-NK improved reduced motivation both 30 min and 24 h after injection in the female encounter test. These results suggest that (S)-NK has potent and long-lasting antidepressant-like effects.

    DOI: 10.1016/j.jphs.2023.12.005

    Web of Science

    Scopus

    PubMed

    researchmap

  9. Activity-dependent organization of prefrontal hub-networks for associative learning and signal transformation 査読有り 国際誌

    Agetsuma, M; Sato, I; Tanaka, YR; Carrillo-Reid, L; Kasai, A; Noritake, A; Arai, Y; Yoshitomo, M; Inagaki, T; Yukawa, H; Hashimoto, H; Nabekura, J; Nagai, T

    NATURE COMMUNICATIONS   14 巻 ( 1 ) 頁: 5996 - 5996   2023年10月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Nature Communications  

    Associative learning is crucial for adapting to environmental changes. Interactions among neuronal populations involving the dorso-medial prefrontal cortex (dmPFC) are proposed to regulate associative learning, but how these neuronal populations store and process information about the association remains unclear. Here we developed a pipeline for longitudinal two-photon imaging and computational dissection of neural population activities in male mouse dmPFC during fear-conditioning procedures, enabling us to detect learning-dependent changes in the dmPFC network topology. Using regularized regression methods and graphical modeling, we found that fear conditioning drove dmPFC reorganization to generate a neuronal ensemble encoding conditioned responses (CR) characterized by enhanced internal coactivity, functional connectivity, and association with conditioned stimuli (CS). Importantly, neurons strongly responding to unconditioned stimuli during conditioning subsequently became hubs of this novel associative network for the CS-to-CR transformation. Altogether, we demonstrate learning-dependent dynamic modulation of population coding structured on the activity-dependent formation of the hub network within the dmPFC.

    DOI: 10.1038/s41467-023-41547-5

    Web of Science

    Scopus

    PubMed

    researchmap

  10. Dorsal raphe serotonergic neurons preferentially reactivate dorsal dentate gyrus cell ensembles associated with positive experience 国際誌

    永井 佑茉, 木坂 優里, 野村 健人, 西谷 直也, 安藤 千紘, 好田 匡志, 河合 洋幸, 勢力 薫, 永安 一樹, 笠井 淳司, 白川 久志, 中澤 敬信, 橋本 均, 金子 周司

    CELL REPORTS   42 巻 ( 3 ) 頁: 112149 - 112149   2023年3月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Elsevier BV  

    Major depressive disorder (MDD) is among the most common mental illnesses. Serotonergic (5-HT) neurons are central to the pathophysiology and treatment of MDD. Repeatedly recalling positive episodes is effective for MDD. Stimulating 5-HT neurons of the dorsal raphe nucleus (DRN) or neuronal ensembles in the dorsal dentate gyrus (dDG) associated with positive memories reverses the stress-induced behavioral abnormalities. Despite this phenotypic similarity, their causal relationship is unclear. This study revealed that the DRN 5-HT neurons activate dDG neurons; surprisingly, this activation was specifically observed in positive memory ensembles rather than neutral or negative ensembles. Furthermore, we revealed that dopaminergic signaling induced by activation of DRN 5-HT neurons projecting to the ventral tegmental area mediates an increase in active coping behavior and positive dDG ensemble reactivation. Our study identifies a role of DRN 5-HT neurons as specific reactivators of positive memories and provides insights into how serotonin elicits antidepressive effects.

    DOI: 10.1016/j.celrep.2023.112149

    Web of Science

    Scopus

    PubMed

    CiNii Research

    researchmap

  11. High-throughput line-illumination Raman microscopy with multislit detection 査読有り 国際誌

    Mochizuki, K; Kumamoto, Y; Maeda, S; Tanuma, M; Kasai, A; Takemura, M; Harada, Y; Hashimoto, H; Tanaka, H; Smith, NI; Fujita, K

    BIOMEDICAL OPTICS EXPRESS   14 巻 ( 3 ) 頁: 1015 - 1026   2023年3月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Biomedical Optics Express  

    Raman microscopy is an emerging tool for molecular imaging and analysis of living samples. Use of Raman microscopy in life sciences is, however, still limited because of its slow measurement speed for spectral imaging and analysis. We developed a multiline-illumination Raman microscope to achieve ultrafast Raman spectral imaging. A spectrophotometer equipped with a periodic array of confocal slits detects Raman spectra from a sample irradiated by multiple line illuminations. A comb-like Raman hyperspectral image is formed on a two-dimensional detector in the spectrophotometer, and a hyperspectral Raman image is acquired by scanning the sample with multiline illumination array. By irradiating a sample with 21 simultaneous illumination lines, we achieved high-throughput Raman hyperspectral imaging of mouse brain tissue, acquiring 1108800 spectra in 11.4 min. We also measured mouse kidney and liver tissue as well as conducted label-free live-cell molecular imaging. The ultrafast Raman hyperspectral imaging enabled by the presented technique will expand the possible applications of Raman microscopy in biological and medical fields.

    DOI: 10.1364/BOE.480611

    Web of Science

    Scopus

    PubMed

    researchmap

    その他リンク: https://opg.optica.org/viewmedia.cfm?URI=boe-14-3-1015&seq=0

  12. Pre-treatment of oncolytic reovirus improves tumor accumulation and intratumoral distribution of PEG-liposomes 査読有り 国際誌

    Eguchi, M; Hirata, S; Ishigami, I; Shuwari, N; Ono, R; Tachibana, M; Tanuma, M; Kasai, A; Hashimoto, H; Ogawara, K; Mizuguchi, H; Sakurai, F

    JOURNAL OF CONTROLLED RELEASE   354 巻   頁: 35 - 44   2023年2月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Journal of Controlled Release  

    PEGylated liposomes (PEG-liposomes) are a promising drug delivery vehicle for tumor targeting because of their efficient tumor disposition profiles via the enhanced permeability and retention (EPR) effect. However, tumor targeting of PEG-liposomes, particularly their delivery inside the tumors, is often disturbed by physical barriers in the tumor, including tumor cells themselves, extracellular matrices, and interstitial pressures. In this study, B16 melanoma tumor-bearing mice were injected intravenously with oncolytic reovirus before administration of PEG-liposomes to enhance PEG-liposomes' tumor disposition. Three days after reovirus administration, significant expression of reovirus sigma 3 protein, elevation of apoptosis-related gene expression, and activation of caspase 3 in the tumors were found. Apoptotic cells were found inside the tumors. These data indicated that reovirus efficiently replicated in the tumors and induced apoptosis of tumor cells. The tumor disposition levels of PEG-liposomes were approximately doubled by reovirus pre-administration, compared with a PBS-pretreated group. PEG-liposomes were widely distributed in the tumors of reovirus-pretreated mice, whereas in the PBS-pretreated group, PEG-liposomes were found mainly around or inside the blood vessels in the tumors. Pre-treatment with reovirus also improved the tumor accumulation of PEG-liposomes in human pancreatic BxPC-3 tumors. 3D imaging analysis of whole BxPC-3 tumors demonstrated that pretreatment with reovirus led to the enhancement of PEG-liposome accumulation inside the tumors. Combination treatment with reovirus and paclitaxel-loaded PEG-liposomes (PTX-PEG-liposomes) significantly suppressed B16 tumor growth. These results provide important information for clinical use of combination therapy of reovirus and nanoparticle-based drug delivery system (DDS).

    DOI: 10.1016/j.jconrel.2022.12.050

    Web of Science

    Scopus

    PubMed

    researchmap

  13. Decreased Expression of EP3 Receptor mRNA in the Brain of Mouse Model of Autism Spectrum Disorder. 査読有り 国際誌

    Anggadiredja K, Kurniati NF, Kasai A, Hashimoto H

    MicroRNA (Shariqah, United Arab Emirates)   12 巻 ( 3 ) 頁: 221 - 226   2023年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.2174/2211536612666230427152647

    PubMed

    researchmap

  14. Parabrachial-to-parasubthalamic nucleus pathway mediates fear-induced suppression of feeding in male mice 査読有り 国際誌

    Nagashima, T; Tohyama, S; Mikami, K; Nagase, M; Morishima, M; Kasai, A; Hashimoto, H; Watabe, AM

    NATURE COMMUNICATIONS   13 巻 ( 1 ) 頁: 7913 - 7913   2022年12月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Nature Communications  

    Feeding behavior is adaptively regulated by external and internal environment, such that feeding is suppressed when animals experience pain, sickness, or fear. While the lateral parabrachial nucleus (lPB) plays key roles in nociception and stress, neuronal pathways involved in feeding suppression induced by fear are not fully explored. Here, we investigate the parasubthalamic nucleus (PSTN), located in the lateral hypothalamus and critically involved in feeding behaviors, as a target of lPB projection neurons. Optogenetic activation of lPB-PSTN terminals in male mice promote avoidance behaviors, aversive learning, and suppressed feeding. Inactivation of the PSTN and lPB-PSTN pathway reduces fear-induced feeding suppression. Activation of PSTN neurons expressing pituitary adenylate cyclase-activating polypeptide (PACAP), a neuropeptide enriched in the PSTN, is sufficient for inducing avoidance behaviors and feeding suppression. Blockade of PACAP receptors impaires aversive learning induced by lPB-PSTN photomanipulation. These findings indicate that lPB-PSTN pathway plays a pivotal role in fear-induced feeding suppression.

    DOI: 10.1038/s41467-022-35634-2

    Web of Science

    Scopus

    PubMed

    researchmap

  15. Acute social defeat stress activated neurons project to the claustrum and basolateral amygdala 査読有り 国際誌

    Tanuma, M; Niu, MSK; Ohkubo, J; Ueno, H; Nakai, Y; Yokoyama, Y; Seiriki, K; Hashimoto, H; Kasai, A

    MOLECULAR BRAIN   15 巻 ( 1 ) 頁: 100 - 100   2022年12月

     詳細を見る

    担当区分:最終著者, 責任著者   記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Molecular Brain  

    We recently reported that a neuronal population in the claustrum (CLA) identified under exposure to psychological stressors plays a key role in stress response processing. Upon stress exposure, the main inputs to the CLA come from the basolateral amygdala (BLA); however, the upstream brain regions that potentially regulate both the CLA and BLA during stressful experiences remain unclear. Here by combining activity-dependent viral retrograde labeling with whole brain imaging, we analyzed neurons projecting to the CLA and BLA activated by exposure to social defeat stress. The labeled CLA projecting neurons were mostly ipsilateral, excluding the prefrontal cortices, which had a distinctly labeled population in the contralateral hemisphere. Similarly, the labeled BLA projecting neurons were predominantly ipsilateral, aside from the BLA in the opposite hemisphere, which also had a notably labeled population. Moreover, we found co-labeled double-projecting single neurons in multiple brain regions such as the ipsilateral ectorhinal/perirhinal cortex, entorhinal cortex, and the contralateral BLA. These results suggest that CLA and BLA receive inputs from neuron collaterals in various brain regions during stress, which may regulate the CLA and BLA forming in a stress response circuitry.

    DOI: 10.1186/s13041-022-00987-8

    Web of Science

    Scopus

    PubMed

    researchmap

  16. Molecular brain (micro report) oxytocin ameliorates impaired social behavior in a mouse model of 3q29 deletion syndrome 査読有り 国際誌

    Takemoto, T; Baba, M; Yokoyama, K; Kitagawa, K; Nagayasu, K; Ago, Y; Seiriki, K; Hayata-Takano, A; Kasai, A; Mori, D; Ozaki, N; Takuma, K; Hashimoto, R; Hashimoto, H; Nakazawa, T

    MOLECULAR BRAIN   15 巻 ( 1 ) 頁: 26 - 26   2022年3月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Molecular Brain  

    Autism spectrum disorder (ASD) is a neurodevelopmental condition characterized by specific social symptoms, restricted interests, stereotyped repetitive behaviors, and delayed language development. The 3q29 microdeletion (3q29del), a recurrent copy number variant, confers a high risk for ASD and schizophrenia, and serves as an important pathological model for investigating the molecular pathogenesis of a large number of neurodevelopmental and psychiatric conditions. Recently, mouse models carrying a deletion of the chromosomal region corresponding to the human 3q29 region (Df/+ mice) were generated and demonstrated neurodevelopmental and psychiatric conditions associated behavioral abnormalities, pointing to the relevance of Df/+ mice as a model for these conditions with high construct and face validity. Currently, the molecular pathogenesis of these behavioral phenotypes in Df/+ mice remains unclear. The oxytocin (OXT) system plays a central role in social behavior across species and has a potential role in ASD. In this study, to elucidate the molecular mechanisms behind impaired social behavior in Df/+ mice, we investigated the possible involvement of OXT signaling in impaired social behavior in Df/+ mice. We demonstrated that OXT administration restored the impaired social behavior in Df/+ mice. We also demonstrated that the number of OXT-positive cells in the paraventricular nucleus (PVN) was significantly lower in Df/+ mice than in wild-type (WT) littermates. Consistent with this, the level of OXT peptide in the cerebral cortex of Df/+ mice was lower than in WT littermates. Our study may provide important insights into the molecular pathophysiological basis of neurodevelopmental and psychiatric conditions, including ASD.

    DOI: 10.1186/s13041-022-00915-w

    Web of Science

    Scopus

    PubMed

    researchmap

  17. Multiple alterations in glutamatergic transmission and dopamine D2 receptor splicing in induced pluripotent stem cell-derived neurons from patients with familial schizophrenia 査読有り 国際誌

    Yamamoto, K; Kuriu, T; Matsumura, K; Nagayasu, K; Tsurusaki, Y; Miyake, N; Yamamori, H; Yasuda, Y; Fujimoto, M; Fujiwara, M; Baba, M; Kitagawa, K; Takemoto, T; Gotoda-Nishimura, N; Takada, T; Seiriki, K; Hayata-Takano, A; Kasai, A; Ago, Y; Kida, S; Takuma, K; Ono, F; Matsumoto, N; Hashimoto, R; Hashimoto, H; Nakazawa, T

    TRANSLATIONAL PSYCHIATRY   11 巻 ( 1 ) 頁: 548 - 548   2021年10月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Translational Psychiatry  

    An increasing body of evidence suggests that impaired synapse development and function are associated with schizophrenia; however, the underlying molecular pathophysiological mechanism of the disease remains largely unclear. We conducted a family-based study combined with molecular and cellular analysis using induced pluripotent stem cell (iPSC) technology. We generated iPSCs from patients with familial schizophrenia, differentiated these cells into neurons, and investigated the molecular and cellular phenotypes of the patient’s neurons. We identified multiple altered synaptic functions, including increased glutamatergic synaptic transmission, higher synaptic density, and altered splicing of dopamine D2 receptor mRNA in iPSC-derived neurons from patients. We also identified patients’ specific genetic mutations using whole-exome sequencing. Our findings support the notion that altered synaptic function may underlie the molecular and cellular pathophysiology of schizophrenia, and that multiple genetic factors cooperatively contribute to the development of schizophrenia.

    DOI: 10.1038/s41398-021-01676-1

    Web of Science

    Scopus

    PubMed

    researchmap

  18. Exploring rare cellular activity in more than one million cells by a transscale scope 査読有り 国際誌

    Ichimura, T; Kakizuka, T; Horikawa, K; Seiriki, K; Kasai, A; Hashimoto, H; Fujita, K; Watanabe, TM; Nagai, T

    SCIENTIFIC REPORTS   11 巻 ( 1 ) 頁: 16539 - 16539   2021年8月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Scientific Reports  

    In many phenomena of biological systems, not a majority, but a minority of cells act on the entire multicellular system causing drastic changes in the system properties. To understand the mechanisms underlying such phenomena, it is essential to observe the spatiotemporal dynamics of a huge population of cells at sub-cellular resolution, which is difficult with conventional tools such as microscopy and flow cytometry. Here, we describe an imaging system named AMATERAS that enables optical imaging with an over-one-centimeter field-of-view and a-few-micrometer spatial resolution. This trans-scale-scope has a simple configuration, composed of a low-power lens for machine vision and a hundred-megapixel image sensor. We demonstrated its high cell-throughput, capable of simultaneously observing more than one million cells. We applied it to dynamic imaging of calcium ions in HeLa cells and cyclic-adenosine-monophosphate in Dictyostelium discoideum, and successfully detected less than 0.01% of rare cells and observed multicellular events induced by these cells.

    DOI: 10.1038/s41598-021-95930-7

    Web of Science

    Scopus

    PubMed

    researchmap

  19. Comprehensive characterization of migration profiles of murine cerebral cortical neurons during development using FlashTag labeling 査読有り 国際誌

    Yoshinaga, S; Shin, M; Kitazawa, A; Ishii, K; Tanuma, M; Kasai, A; Hashimoto, H; Kubo, KI; Nakajima, K

    ISCIENCE   24 巻 ( 4 ) 頁: 102277 - 102277   2021年4月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:iScience  

    In the mammalian cerebral neocortex, different regions have different cytoarchitecture, neuronal birthdates, and functions. In most regions, neuronal migratory profiles are speculated similar based on observations using thymidine analogs. Few reports have investigated regional migratory differences from mitosis at the ventricular surface. In this study, we applied FlashTag technology, in which dyes are injected intraventricularly, to describe migratory profiles. We revealed a mediolateral regional difference in the migratory profiles of neurons that is dependent on developmental stage; for example, neurons labeled at embryonic day 12.5–15.5 reached their destination earlier dorsomedially than dorsolaterally, even where there were underlying ventricular surfaces, reflecting sojourning below the subplate. This difference was hardly recapitulated by thymidine analogs, which visualize neurogenic gradients, suggesting a biological significance different from the neurogenic gradient. These observations advance our understanding of cortical development and the power of FlashTag in studying migration and are thus resources for future neurodevelopmental studies.

    DOI: 10.1016/j.isci.2021.102277

    Web of Science

    Scopus

    PubMed

    researchmap

  20. Intranasal oxytocin administration ameliorates social behavioral deficits in a <i>POGZ</i><SUP>WT/Q10</SUP><SUP>38R</SUP> mouse model of autism spectrum disorder 査読有り 国際誌

    Kitagawa, K; Matsumura, K; Baba, M; Kondo, M; Takemoto, T; Nagayasu, K; Ago, Y; Seiriki, K; Hayata-Takano, A; Kasai, A; Takuma, K; Hashimoto, R; Hashimoto, H; Nakazawa, T

    MOLECULAR BRAIN   14 巻 ( 1 ) 頁: 56 - 56   2021年3月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Molecular Brain  

    Autism spectrum disorder (ASD) is a highly prevalent neurodevelopmental disorder characterized by core symptoms of impaired social behavior and communication. Recent studies have suggested that the oxytocin system, which regulates social behavior in mammals, is potentially involved in ASD. Mouse models of ASD provide a useful system for understanding the associations between an impaired oxytocin system and social behavior deficits. However, limited studies have shown the involvement of the oxytocin system in the behavioral phenotypes in mouse models of ASD. We have previously demonstrated that a mouse model that carries the ASD patient-derived de novo mutation in the pogo transposable element derived with zinc finger domain (POGZWT/Q1038R mice), showed ASD-like social behavioral deficits. Here, we have explored whether oxytocin (OXT) administration improves impaired social behavior in POGZWT/Q1038R mice and found that intranasal oxytocin administration effectively restored the impaired social behavior in POGZWT/Q1038R mice. We also found that the expression level of the oxytocin receptor gene (OXTR) was low in POGZWT/Q1038R mice. However, we did not detect significant changes in the number of OXT-expressing neurons between the paraventricular nucleus of POGZWT/Q1038R mice and that of WT mice. A chromatin immunoprecipitation assay revealed that POGZ binds to the promoter region of OXTR and is involved in the transcriptional regulation of OXTR. In summary, our study demonstrate that the pathogenic mutation in the POGZ, a high-confidence ASD gene, impairs the oxytocin system and social behavior in mice, providing insights into the development of oxytocin-based therapeutics for ASD.

    DOI: 10.1186/s13041-021-00769-8

    Web of Science

    Scopus

    PubMed

    researchmap

  21. Altered Functional Connectivity of the Orbital Cortex and Striatum Associated with Catalepsy Induced by Dopamine D1 and D2 Antagonists

    Niu, M; Kasai, A; Seiriki, K; Hayashida, M; Tanuma, M; Yokoyama, R; Hirato, Y; Hashimoto, H

    Biological & Pharmaceutical Bulletin   44 巻 ( 3 ) 頁: 442 - 447   2021年3月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:公益社団法人 日本薬学会  

    The dopamine system plays an important role in regulating many brain functions, including the motor function. The blockade of dopamine receptors results in a serious motor dysfunction, such as catalepsy and Parkinsonism. However, the neuronal mechanism underlying the drug-induced motor dysfunction is not well understood. Here, we examine brain-wide activation patterns in Fos-enhanced green fluorescent protein reporter mice that exhibit cataleptic behavior induced by SCH39166, a dopamine D1-like receptor antagonist, and raclopride, a dopamine D2-like receptor antagonist. Support vector classifications showed that the orbital cortex (ORB) and striatum including the caudoputamen (CP) and nucleus accumbens (ACB), prominently contribute to the discrimination between brains of the vehicle-treated and both SCH39166- and raclopride-treated mice. Interregional correlations indicated that the increased functional connectivity of functional networks, including the ORB, CP, and ACB, is the common mechanism underlying SCH39166- and raclopride-induced cataleptic behavior. Moreover, the distinct mechanisms in the SCH39166- and raclopride-induced cataleptic behaviors are the decreased functional connectivity between three areas above and the cortical amygdala, and between three areas above and the anterior cingulate cortex, respectively. Thus, the alterations of functional connectivity in diverse brain regions, including the ORB, provide new insights on the mechanism underlying drug-induced movement disorders.

    DOI: 10.1248/bpb.b20-01006

    Web of Science

    Scopus

    PubMed

    CiNii Research

    researchmap

  22. Lipocalin-type prostaglandin D synthase regulates light-induced phase advance of the central circadian rhythm in mice 査読有り 国際誌

    Kawaguchi, C; Shintani, N; Hayata-Takano, A; Hatanaka, M; Kuromi, A; Nakamura, R; Yamano, Y; Shintani, Y; Nagai, K; Tsuchiya, S; Sugimoto, Y; Ichikawa, A; Okuno, Y; Urade, Y; Hirai, H; Nagata, K; Nakamura, M; Narumiya, S; Nakazawa, T; Kasai, A; Ago, Y; Takuma, K; Baba, A; Hashimoto, H

    COMMUNICATIONS BIOLOGY   3 巻 ( 1 ) 頁: 557 - 557   2020年10月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Communications Biology  

    We previously showed that mice lacking pituitary adenylate cyclase-activating polypeptide (PACAP) exhibit attenuated light-induced phase shift. To explore the underlying mechanisms, we performed gene expression analysis of laser capture microdissected suprachiasmatic nuclei (SCNs) and found that lipocalin-type prostaglandin (PG) D synthase (L-PGDS) is involved in the impaired response to light stimulation in the late subjective night in PACAP-deficient mice. L-PGDS-deficient mice also showed impaired light-induced phase advance, but normal phase delay and nonvisual light responses. Then, we examined the receptors involved in the response and observed that mice deficient for type 2 PGD2 receptor DP2/CRTH2 (chemoattractant receptor homologous molecule expressed on Th2 cells) show impaired light-induced phase advance. Concordant results were observed using the selective DP2/CRTH2 antagonist CAY10471. These results indicate that L-PGDS is involved in a mechanism of light-induced phase advance via DP2/CRTH2 signaling.

    DOI: 10.1038/s42003-020-01281-w

    Web of Science

    Scopus

    PubMed

    researchmap

  23. (<i>S</i>)-norketamine and (<i>2S, 6S</i>)-hydroxynorketamine exert potent antidepressant-like effects in a chronic corticosterone-induced mouse model of depression 査読有り 国際誌

    Yokoyama, R; Higuchi, M; Tanabe, W; Tsukada, S; Naito, M; Yamaguchi, T; Chen, L; Kasai, A; Seiriki, K; Nakazawa, T; Nakagawa, S; Hashimoto, K; Hashimoto, H; Ago, Y

    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR   191 巻   頁: 172876 - 172876   2020年4月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Pharmacology Biochemistry and Behavior  

    Clinical and preclinical studies have shown that the N-methyl-D-aspartate receptor antagonist ketamine exerts rapid and long-lasting antidepressant effects. Although ketamine metabolites might also have potential antidepressant properties, controversial results have been reported for (2R,6R)-hydroxynorketamine ((2R,6R)-HNK) in particular, and there is little information regarding the effects of other ketamine metabolites. Here we aimed to compare the effects of (R)-norketamine ((R)-NK), (S)-NK, (2R,6R)-HNK, and (2S,6S)-HNK in a mouse model of depression induced by chronic corticosterone (CORT) injection. None of the ketamine metabolites at doses up to 20 mg/kg showed antidepressant-like activity in naïve male C57BL6/J mice. Chronic CORT treatment increased immobility in the forced swim test and caused anhedonic-like behaviors in the female encounter test. A single administration of (S)-NK and (2S,6S)-HNK dose-dependently reduced the enhanced immobility at 30 min after injection in chronic CORT-treated mice, while (R)-NK or (2R,6R)-HNK did not. Additionally, (S)-NK and (2S,6S)-HNK, but not (R)-NK or (2R,6R)-HNK, improved chronic CORT-induced anhedonia at 24 h after the injection. These results suggest that (S)-ketamine metabolites (S)-NK and (2S,6S)-HNK have potent acute and sustained antidepressant effects in rodents.

    DOI: 10.1016/j.pbb.2020.172876

    Web of Science

    Scopus

    PubMed

    researchmap

  24. Pathogenic POGZ mutation causes impaired cortical development and reversible autism-like phenotypes 査読有り 国際誌

    Matsumura, K; Seiriki, K; Okada, S; Nagase, M; Ayabe, S; Yamada, I; Furuse, T; Shibuya, H; Yasuda, Y; Yamamori, H; Fujimoto, M; Nagayasu, K; Yamamoto, K; Kitagawa, K; Miura, H; Gotoda-Nishimura, N; Igarashi, H; Hayashida, M; Masayuki; Kondo, M; Hasebe, S; Ueshima, K; Kasai, A; Ago, Y; Hayata-Takano, A; Shintani, N; Iguchi, T; Sato, M; Yamaguchi, S; Tamura, M; Wakana, S; Yoshiki, A; Watabe, AM; Okano, H; Takuma, K; Hashimoto, R; Hashimoto, H; Nakazawa, T

    NATURE COMMUNICATIONS   11 巻 ( 1 ) 頁: 859 - 859   2020年2月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Nature Communications  

    Pogo transposable element derived with ZNF domain (POGZ) has been identified as one of the most recurrently de novo mutated genes in patients with neurodevelopmental disorders (NDDs), including autism spectrum disorder (ASD), intellectual disability and White-Sutton syndrome; however, the neurobiological basis behind these disorders remains unknown. Here, we show that POGZ regulates neuronal development and that ASD-related de novo mutations impair neuronal development in the developing mouse brain and induced pluripotent cell lines from an ASD patient. We also develop the first mouse model heterozygous for a de novo POGZ mutation identified in a patient with ASD, and we identify ASD-like abnormalities in the mice. Importantly, social deficits can be treated by compensatory inhibition of elevated cell excitability in the mice. Our results provide insight into how de novo mutations on high-confidence ASD genes lead to impaired mature cortical network function, which underlies the cellular pathogenesis of NDDs, including ASD.

    DOI: 10.1038/s41467-020-14697-z

    Web of Science

    Scopus

    PubMed

    researchmap

  25. Autism-associated protein kinase D2 regulates embryonic cortical neuron development 査読有り 国際誌

    Matsumura, K; Baba, M; Nagayasu, K; Yamamoto, K; Kondo, M; Kitagawa, K; Takemoto, T; Seiriki, K; Kasai, A; Ago, Y; Hayata-Takano, A; Shintani, N; Kuriu, T; Iguchi, T; Sato, M; Takuma, K; Hashimoto, R; Hashimoto, H; Nakazawa, T

    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS   519 巻 ( 3 ) 頁: 626 - 632   2019年11月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Biochemical and Biophysical Research Communications  

    Autism spectrum disorder (ASD) is a heterogeneous neurodevelopmental disorder, characterized by impaired social interaction, repetitive behavior and restricted interests. Although the molecular etiology of ASD remains largely unknown, recent studies have suggested that de novo mutations are significantly involved in the risk of ASD. We and others recently identified spontaneous de novo mutations in PKD2, a protein kinase D family member, in sporadic ASD cases. However, the biological significance of the de novo PKD2 mutations and the role of PKD2 in brain development remain unclear. Here, we performed functional analysis of PKD2 in cortical neuron development using in utero electroporation. PKD2 is highly expressed in cortical neural stem cells in the developing cortex and regulates cortical neuron development, including the neuronal differentiation of neural stem cells and migration of newborn neurons. Importantly, we determined that the ASD-associated de novo mutations impair the kinase activity of PKD2, suggesting that the de novo PKD2 mutations can be a risk factor for the disease by loss of function of PKD2. Our current findings provide novel insight into the molecular and cellular pathogenesis of ASD.

    DOI: 10.1016/j.bbrc.2019.09.048

    Web of Science

    Scopus

    PubMed

    researchmap

  26. Psychiatric-disorder-related behavioral phenotypes and cortical hyperactivity in a mouse model of 3q29 deletion syndrome 査読有り 国際誌

    Baba, M; Yokoyama, K; Seiriki, K; Naka, Y; Matsumura, K; Kondo, M; Yamamoto, K; Hayashida, M; Kasai, A; Ago, Y; Nagayasu, K; Hayata-Takano, A; Takahashi, A; Yamaguchi, S; Mori, D; Ozaki, N; Yamamoto, T; Takuma, K; Hashimoto, R; Hashimoto, H; Nakazawa, T

    NEUROPSYCHOPHARMACOLOGY   44 巻 ( 12 ) 頁: 2125 - 2135   2019年11月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Neuropsychopharmacology  

    3q29 microdeletion, a rare recurrent copy number variant (CNV), greatly confers an increased risk of psychiatric disorders, such as schizophrenia and autism spectrum disorder (ASD), as well as intellectual disability. However, disease-relevant cellular phenotypes of 3q29 deletion syndrome remain to be identified. To reveal the molecular and cellular etiology of 3q29 deletion syndrome, we generated a mouse model of human 3q29 deletion syndrome by chromosome engineering, which achieved construct validity. 3q29 deletion (Df/+) mice showed reduced body weight and brain volume and, more importantly, impaired social interaction and prepulse inhibition. Importantly, the schizophrenia-related impaired prepulse inhibition was reversed by administration of antipsychotics. These findings are reminiscent of the growth defects and neuropsychiatric behavioral phenotypes in patients with 3q29 deletion syndrome and exemplify that the mouse model achieves some part of face validity and predictive validity. Unbiased whole-brain imaging revealed that neuronal hyperactivation after a behavioral task was strikingly exaggerated in a restricted region of the cortex of Df/+ mice. We further elucidated the cellular phenotypes of neuronal hyperactivation and the reduction of parvalbumin expression in the cortex of Df/+ mice. Thus, the 3q29 mouse model provides invaluable insight into the disease-causative molecular and cellular pathology of psychiatric disorders.

    DOI: 10.1038/s41386-019-0441-5

    Web of Science

    Scopus

    PubMed

    researchmap

  27. (<i>R</i>)-Ketamine Induces a Greater Increase in Prefrontal 5-HT Release Than (<i>S</i>)-Ketamine and Ketamine Metabolites via an AMPA Receptor-Independent Mechanism 査読有り 国際誌

    Ago, Y; Tanabe, W; Higuchi, M; Tsukada, S; Tanaka, T; Yamaguchi, T; Igarashi, H; Yokoyama, R; Seiriki, K; Kasai, A; Nakazawa, T; Nakagawa, S; Hashimoto, K; Hashimoto, H

    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY   22 巻 ( 10 ) 頁: 665 - 674   2019年10月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:International Journal of Neuropsychopharmacology  

    Background: Although recent studies provide insight into the molecular mechanisms of the effects of ketamine, the antidepressant mechanism of ketamine enantiomers and their metabolites is not fully understood. In view of the involvement of mechanisms other than the N-methyl-D-aspartate receptor in ketamine's action, we investigated the effects of (R)-ketamine, (S)-ketamine, (R)-norketamine [(R)-NK], (S)-NK, (2R,6R)-hydroxynorketamine [(2R,6R)-HNK], and (2S,6S)-HNK on monoaminergic neurotransmission in the prefrontal cortex of mice. Methods: The extracellular monoamine levels in the prefrontal cortex were measured by in vivo microdialysis. Results: (R)-Ketamine and (S)-ketamine acutely increased serotonin release in a dose-dependent manner, and the effect of (R)-ketamine was greater than that of (S)-ketamine. In contrast, (S)-ketamine caused a robust increase in dopamine release compared with (R)-ketamine. Both ketamine enantiomers increased noradrenaline release, but these effects did not differ. (2R,6R)-HNK caused a slight but significant increase in serotonin and noradrenaline but not dopamine release. (S)-NK increased dopamine and noradrenaline but not serotonin release. Differential effects between (R)-ketamine and (S)-ketamine were also observed in a lipopolysaccharide-induced model of depression. An α-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA) receptor antagonist, 2,3-dioxo-6-nitro-1,2,3,4- tetrahydrobenzo[f]quinoxaline-7-sulfonamide (NBQX), attenuated (S)-ketamine-induced, but not (R)-ketamine-induced serotonin release, whereas NBQX blocked dopamine release induced by both enantiomers. Local application of (R)-ketamine into the prefrontal cortex caused a greater increase in prefrontal serotonin release than that of (S)-ketamine. Conclusions: (R)-Ketamine strongly activates the prefrontal serotonergic system through an AMPA receptor-independent mechanism. (S)-Ketamine-induced serotonin and dopamine release was AMPA receptor-dependent. These findings provide a neurochemical basis for the underlying pharmacological differences between ketamine enantiomers and their metabolites.

    DOI: 10.1093/ijnp/pyz041

    Web of Science

    Scopus

    PubMed

    researchmap

  28. Pituitary Adenylate Cyclase-Activating Polypeptide Modulates Dendritic Spine Maturation and Morphogenesis via MicroRNA-132 Upregulation 査読有り 国際誌

    Hayata-Takano, A; Kamo, T; Kijima, H; Seiriki, K; Ogata, O; Ago, Y; Nakazawa, T; Shintani, Y; Higashino, K; Nagayasu, O; Shintani, N; Kasai, A; Waschek, JA; Hashimoto, H

    JOURNAL OF NEUROSCIENCE   39 巻 ( 22 ) 頁: 4208 - 4220   2019年5月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Journal of Neuroscience  

    Alterations in pituitary adenylate cyclase-activating polypeptide (PACAP), a multifunctional neuropeptide, and its receptors have been identified as risk factors for certain psychiatric disorders, including schizophrenia. Increasing evidence from human genetic and animal model studies suggest an association between various psychiatric disorders and altered dendritic spine morphology. In the present study, we investigated the role of exogenous and endogenous PACAP in spine formation and maturation. PACAP modified the density and morphology of PSD-95-positive spines in primary cultured hippocampal neurons. Notably, PACAP increased the levels of microRNA (miR)-132 and decreased expression of corresponding miR-132 target genes and protein expression of p250GAP, a miR-132 effector known to be involved in spine morphology regulation. In corroboration, PSD-95-positive spines were reduced in PACAP-deficient (PACAP_/_) mice versusWTmice. Golgi staining of hippocampal CA1 neurons revealed a reduced spine densities and atypical morphologies in the male PACAP_/_ mice. Furthermore, viral miR-132 overexpression reversed the reduction in hippocampal spinal density in the male PACAP_/_ mice. These results indicate that PACAP signaling plays a critical role in spine morphogenesis possibly via miR-132. Wesuggest that dysfunction ofPACAPsignalingmaycontribute to the pathogenesis of neuropsychiatric disorders, at least partly through its effects on spine formation.

    DOI: 10.1523/JNEUROSCI.2468-18.2019

    Web of Science

    Scopus

    PubMed

    researchmap

  29. mS-11, a mimetic of the mSin3-binding helix in NRSF, ameliorates social interaction deficits in a prenatal valproic acid-induced autism mouse model 査読有り 国際誌

    Kawase, H; Ago, Y; Naito, M; Higuchi, M; Hara, Y; Hasebe, S; Tsukada, S; Kasai, A; Nakazawa, T; Mishina, T; Kouji, H; Takuma, K; Hashimoto, H

    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR   176 巻   頁: 1 - 5   2019年1月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Pharmacology Biochemistry and Behavior  

    Growing evidence suggests pivotal roles for epigenetic mechanisms in both animal models of and individuals with autism spectrum disorders (ASD). Neuron-restrictive silencer factor (NRSF) binds to neuron-restrictive silencing elements in neuronal genes and recruits co-repressors, such as mSin3, to epigenetically inhibit neuronal gene expression. Because dysregulation of NRSF is related to ASD, here we examined the effects of mS-11, a chemically optimized mimetic of the mSin3-binding helix in NRSF, on the behavioral and morphological abnormalities found in a mouse model of valproic acid (VPA)-induced ASD. Chronic treatment with mS-11 improved prenatal VPA-induced deficits in social interaction. Additionally, we found that NRSF mRNA expression was greater in the somatosensory cortex of VPA-exposed mice than of controls. Agreeing with these behavioral findings, mice that were prenatally exposed to VPA showed lower dendritic spine density in the somatosensory cortex, which was reversed by chronic treatment with mS-11. These findings suggest that mS-11 has the potential for improving ASD-related symptoms through inhibition of mSin3-NRSF binding.

    DOI: 10.1016/j.pbb.2018.11.003

    Web of Science

    Scopus

    PubMed

    researchmap

  30. 脳機能の解明に向けた全脳神経活動マッピング

    笠井 淳司, 勢力 薫, 橋本 均

    日本薬理学雑誌   153 巻 ( 6 ) 頁: 278 - 283   2019年

     詳細を見る

    記述言語:日本語   掲載種別:研究論文(学術雑誌)   出版者・発行元:公益社団法人 日本薬理学会  

    <p>脳機能は,複雑な神経ネットワークの情報伝達を介した個々の神経細胞の活動により制御されている.そのため,脳機能を理解するには,個々の神経細胞の活動を統合的に把握する必要がある.個々の神経細胞の活動を記録する方法としては,これまで電気生理学的な手法やカルシウムイメージング法などが汎用されてきた.しかしながら,これらの手法では,脳のごく一部の神経細胞の活動を記録することしかできず,神経活動の統合的な理解は困難であった.そこで最近,全ての神経活動を網羅的に検出する全脳全細胞活動マッピング法が開発されている.これを可能にしたのは,筆者らが開発したFASTシステムを含め,単一細胞を識別できる空間解像度で全脳をイメージングする光学顕微鏡技術である.単一細胞レベルの全脳イメージング法と神経活動レポーターマウスなどと組み合わせることにより,全ての脳領域から全細胞活動の情報を取得できるようになってきた.そこで本稿では,筆者らのFASTシステムを中心に高精細な全脳イメージング法について紹介し,さらに全脳神経活動マッピングの実施例とその解析法について紹介したい.</p>

    DOI: 10.1254/fpj.153.278

    Scopus

    PubMed

    CiNii Research

    researchmap

  31. Saturated excitation microscopy using differential excitation for efficient detection of nonlinear fluorescence signals 査読有り

    Nawa, Y; Yonemaru, Y; Kasai, A; Oketani, R; Hashimoto, H; Smith, NI; Fujita, K

    APL PHOTONICS   3 巻 ( 8 ) 頁: 080805 - 080805   2018年8月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:APL Photonics  

    We report a method to increase the efficiency of detecting nonlinear fluorescence signals in saturated excitation (SAX) microscopy. With this method, we compare fluorescence signals obtained under different degrees of saturated excitation to extract the nonlinear fluorescent signal induced by saturated excitation. Compared to conventional SAX microscopy using the harmonic demodulation technique, the detection efficiency of the fluorescence signal can be increased up to 8 and 32 times in imaging using the second-order and the third-order nonlinear fluorescence signals, respectively. We combined this approach with pulsed excitation, which is effective to reduce photobleaching effects, and achieved super-resolution imaging using third-order nonlinear fluorescence signals induced by saturated excitation of an organic dye. The resolution improvement was confirmed in the observations of fluorescent beads, actin-filaments in HeLa cells, and a spine in mouse brain tissue.

    DOI: 10.1063/1.5039567

    Web of Science

    Scopus

    researchmap

  32. β-Arrestin1 and 2 differentially regulate PACAP-induced PAC1 receptor signaling and trafficking 査読有り 国際誌

    Shintani, Y; Hayata-Takano, A; Moriguchi, K; Nakazawa, T; Ago, Y; Kasai, A; Seiriki, K; Shintani, N; Hashimoto, H

    PLOS ONE   13 巻 ( 5 ) 頁: e0196946   2018年5月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:PLoS ONE  

    A pituitary adenylate cyclase-activating polypeptide (PACAP)-specific receptor, PAC1R, is coupled with multiple signal transduction pathways including stimulation of adenylate cyclase, phospholipase C and extracellular-signal regulated kinase (ERK)1/2. PAC1R has been shown to exert its long-lasting and potent signals via β-arrestin1 and β-arrestin2. However, the precise roles of the two β-arrestin isoforms in PACAP-PAC1R signaling remain unclear. Here we examined the interaction between the two β-arrestin isoforms and PAC1R, β-arrestin-dependent PAC1R subcellular localization and ERK1/2 activation. Upon PACAP stimulation, although PAC1R similarly interacted with β-arrestin1 and β-arrestin2 in HEK293T cells, the complex of PAC1R and β-arrestin2 was translocated from the cell surface into cytosol, but that of β-arrestin1 remained in the cell surface regions in HeLa cells and mouse primary cultured neurons. Silencing of β-arrestin2 blocked PACAP-induced PAC1R internalization and ERK1/2 phosphorylation, but silencing of β-arrestin1 increased ERK1/2 phosphorylation. These results show that β-arrestin1 and β-arrestin2 exert differential actions on PAC1R internalization and PAC1R-dependent ERK1/2 activation, and suggest that the two β-arrestin isoforms may be involved in fine and precise tuning of the PAC1R signaling pathways.

    DOI: 10.1371/journal.pone.0196946

    Web of Science

    Scopus

    PubMed

    researchmap

  33. Knockdown of the mitochondria-localized protein p13 protects against experimental parkinsonism 査読有り

    Inoue, N; Ogura, S; Kasai, A; Nakazawa, T; Ikeda, K; Higashi, S; Isotani, A; Baba, K; Mochizuki, H; Fujimura, H; Ago, Y; Hayata-Takano, A; Seiriki, K; Shintani, Y; Shintani, N; Hashimoto, H

    EMBO REPORTS   19 巻 ( 3 )   2018年3月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:EMBO Reports  

    Mitochondrial dysfunction in the nigrostriatal dopaminergic system is a critical hallmark of Parkinson's disease (PD). Mitochondrial toxins produce cellular and behavioural dysfunctions resembling those in patients with PD. Causative gene products for familial PD play important roles in mitochondrial function. Therefore, targeting proteins that regulate mitochondrial integrity could provide convincing strategies for PD therapeutics. We have recently identified a novel 13-kDa protein (p13) that may be involved in mitochondrial oxidative phosphorylation. In the current study, we examine the mitochondrial function of p13 and its involvement in PD pathogenesis using mitochondrial toxin-induced PD models. We show that p13 overexpression induces mitochondrial dysfunction and apoptosis. p13 knockdown attenuates toxin-induced mitochondrial dysfunction and apoptosis in dopaminergic SH-SY5Y cells via the regulation of complex I. Importantly, we generate p13-deficient mice using the CRISPR/Cas9 system and observe that heterozygous p13 knockout prevents toxin-induced motor deficits and the loss of dopaminergic neurons in the substantia nigra. Taken together, our results suggest that manipulating p13 expression may be a promising avenue for therapeutic intervention in PD.

    DOI: 10.15252/embr.201744860

    Web of Science

    Scopus

    PubMed

    researchmap

  34. Unbiased compound screening with a reporter gene assay highlights the role of p13 in the cardiac cellular stress response 査読有り 国際誌

    Inoue, N; Hirouchi, T; Kasai, A; Higashi, S; Hiraki, N; Tanaka, S; Nakazawa, T; Nunomura, K; Lin, BZ; Omori, A; Hayata-Takano, A; Kim, YJ; Doi, T; Baba, A; Hashimoto, H; Shintani, N

    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS   495 巻 ( 2 ) 頁: 1992 - 1997   2018年1月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Biochemical and Biophysical Research Communications  

    We recently showed that a 13-kDa protein (p13), the homolog protein of formation of mitochondrial complex V assembly factor 1 in yeast, acts as a potential protective factor in pancreatic islets under diabetes. Here, we aimed to identify known compounds regulating p13 mRNA expression to obtain therapeutic insight into the cellular stress response. A luciferase reporter system was developed using the putative promoter region of the human p13 gene. Overexpression of peroxisome proliferator-activated receptor gamma coactivator 1α, a master player regulating mitochondrial metabolism, increased both reporter activity and p13 expression. Following unbiased screening with 2320 known compounds in HeLa cells, 12 pharmacological agents (including 8 cardiotonics and 2 anthracyclines) that elicited >2-fold changes in p13 mRNA expression were identified. Among them, four cardiac glycosides decreased p13 expression and concomitantly elevated cellular oxidative stress. Additional database analyses showed highest p13 expression in heart, with typically decreased expression in cardiac disease. Accordingly, our results illustrate the usefulness of unbiased compound screening as a method for identifying novel functional roles of unfamiliar genes. Our findings also highlight the importance of p13 in the cellular stress response in heart.

    DOI: 10.1016/j.bbrc.2017.11.116

    Web of Science

    Scopus

    PubMed

    researchmap

  35. Differential gene expression profiles in neurons generated from lymphoblastoid B-cell line-derived iPS cells frommonozygotic twin cases with treatment-resistant schizophrenia and discordant responses to clozapine 査読有り

    Nakazawa, T; Kikuchi, M; Ishikawa, M; Yamamori, H; Nagayasu, K; Matsumoto, T; Fujimoto, M; Yasuda, Y; Fujiwara, M; Okada, S; Matsumura, K; Kasai, A; Hayata-Takano, A; Shintani, N; Numata, S; Takuma, K; Akamatsu, W; Okano, H; Nakaya, A; Hashimoto, H; Hashimoto, R

    SCHIZOPHRENIA RESEARCH   181 巻   頁: 75 - 82   2017年3月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Schizophrenia Research  

    Schizophrenia is a chronic psychiatric disorder with complex genetic and environmental origins. While many antipsychotics have been demonstrated as effective in the treatment of schizophrenia, a substantial number of schizophrenia patients are partially or fully unresponsive to the treatment. Clozapine is the most effective antipsychotic drug for treatment-resistant schizophrenia; however, clozapine has rare but serious side-effects. Furthermore, there is inter-individual variability in the drug response to clozapine treatment. Therefore, the identification of the molecular mechanisms underlying the action of clozapine and drug response predictors is imperative. In the present study, we focused on a pair of monozygotic twin cases with treatment-resistant schizophrenia, in which one twin responded well to clozapine treatment and the other twin did not. Using induced pluripotent stem (iPS) cell-based technology, we generated neurons from iPS cells derived from these patients and subsequently performed RNA-sequencing to compare the transcriptome profiles of the mock or clozapine-treated neurons. Although, these iPS cells similarly differentiated into neurons, several genes encoding homophilic cell adhesion molecules, such as protocadherin genes, showed differential expression patterns between these two patients. These results, which contribute to the current understanding of the molecular mechanisms of clozapine action, establish a new strategy for the use of monozygotic twin studies in schizophrenia research.

    DOI: 10.1016/j.schres.2016.10.012

    Web of Science

    Scopus

    PubMed

    researchmap

  36. ASD-Associated De Novo Mutations in POGZ Impair the DNA-Binding Activity of POGZ 査読有り

    Nakazawa, T; Matsumura, K; Nagayasu, K; Kasai, A; Hayata-Takano, A; Shintani, N; Takuma, K; Yamamori, H; Yasuda, Y; Hashimoto, R; Hashimoto, H

    NEUROPSYCHOPHARMACOLOGY   41 巻   頁: S347 - S348   2016年12月

     詳細を見る

    担当区分:筆頭著者, 責任著者   記述言語:英語  

    Web of Science

  37. Critical involvement of the orbitofrontal cortex in hyperlocomotion induced by NMDA receptor blockade in mice 査読有り

    Seiriki, K; Kasai, A; Kuwaki, T; Nakazawa, T; Yamaguchi, S; Hashimoto, H

    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS   480 巻 ( 4 ) 頁: 558 - 563   2016年11月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Biochemical and Biophysical Research Communications  

    Glutamatergic N-methyl-D-aspartate (NMDA) receptors play critical roles in several neurological and psychiatric diseases. Blockade by noncompetitive NMDA receptor antagonist leads to psychotomimetic effects; however, the brain regions responsible for the effects are not well understood. Here, we determined the specific brain regions responsive to MK-801, a noncompetitive NMDA receptor antagonist, by mapping Arc expression as an indicator of neuronal activity using Arc::dVenus reporter mice. MK-801 increased dVenus expression predominantly in the orbitofrontal cortex (OFC) and, as expected, induced a marked hyperlocomotion. Local OFC lesions selectively attenuated the early phase (0–30 min) of MK-801-induced hyperlocomotion. Further, clozapine, an atypical antipsychotic, effectively attenuated both the MK-801-induced dVenus expression in the OFC and hyperlocomotion. These results suggest that the OFC may be critically involved in NMDA receptor-mediated psychotic-like behavioral abnormalities.

    DOI: 10.1016/j.bbrc.2016.10.089

    Web of Science

    Scopus

    PubMed

    researchmap

  38. Double <i>In situ</i> Hybridization for MicroRNAs and mRNAs in Brain Tissues 査読有り

    Kasai, A; Kakihara, S; Miura, H; Okada, R; Hayata-Takano, A; Hazama, K; Niu, M; Shintani, N; Nakazawa, T; Hashimoto, H

    FRONTIERS IN MOLECULAR NEUROSCIENCE   9 巻 ( NOV2016 ) 頁: 126   2016年11月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Frontiers in Molecular Neuroscience  

    MicroRNAs (miRNAs) participate in a variety of functions in the brain. Understanding the in vivo localization of miRNAs is an important step for uncovering their roles in brain function. However, the in situ detection of low-abundance miRNAs in brain tissues remains difficult and requires extensive optimization of in situ hybridization (ISH) protocols in individual laboratories. Thus, detailed information regarding experimental conditions would serve as a useful reference for researchers in this field. Here, we investigated and summarized the effects of adjusting a series of critical steps, including tissue fixation, probe accessibility and hybridization stringency, to standardize the currently used miRNA ISH procedures. As a result, we successfully detected several low-abundance miRNAs by ISH using the following experimental conditions: (1) use of fresh brain tissues, (2) digestion of brain samples with proteinase K, (3) LNA-probe hybridization at a temperature 37°C below the melting temperature of the RNA, (4) performance of high-stringency wash steps using 50% formamide in 1 × standard saline citrate (SSC) buffer. RT-PCR of the punched-out tissues using TaqManTMprimers confirmed the ISH results. Finally, double-fluorescence ISH successfully demonstrated the colocalization of miRNAs and mRNAs. Thus, the detailed information regarding the miRNA ISH procedures used in this study may help to resolve the technical hurdles observed in the in vivo localization of miRNAs, and the elucidation of the specific roles of miRNAs.

    DOI: 10.3389/fnmol.2016.00126

    Web of Science

    Scopus

    PubMed

    researchmap

  39. Prostaglandin D<sub>2</sub> signaling mediated by the CRTH2 receptor is involved in MK-801-induced cognitive dysfunction 査読有り

    Onaka, Y; Shintani, N; Nakazawa, T; Kanoh, T; Ago, Y; Matsuda, T; Hashimoto, R; Ohi, K; Hirai, H; Nagata, KY; Nakamura, M; Kasai, A; Hayata-Takano, A; Nagayasu, K; Takuma, K; Ogawa, A; Baba, A; Hashimoto, H

    BEHAVIOURAL BRAIN RESEARCH   314 巻   頁: 77 - 86   2016年11月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Behavioural Brain Research  

    Chemoattractant receptor-homologous molecule expressed on T helper type 2 cells (CRTH2), which is a second receptor for prostaglandin (PG) D2, is involved in inflammatory responses in peripheral tissue; however, its role in cognitive function remains unclear. Here, we demonstrate that CRTH2 is involved in cognitive function using a well-established animal model of cognitive dysfunction induced by MK-801, an N-methyl-D-aspartate receptor antagonist. Genetic deletion and pharmacological inhibition of CRTH2 suppressed MK-801-induced cognitive dysfunction. Pharmacological inhibition of cyclooxygenase-1, a rate-limiting enzyme in PG synthesis, also suppressed MK-801-induced cognitive dysfunction. Moreover, an MK-801-induced increase in c-Fos expression in the paraventricular nucleus (PVN) was abolished in the CRTH2-deficient mice. Together, these results suggest that PGD2-CRTH2 signaling is involved in both MK-801-induced cognitive dysfunction and neuronal activity regulation in the PVN. Furthermore, genetic association studies suggest that CRTH2 is weakly associated with cognitive function in humans. Our study provides evidence that PGD2-CRTH2 signaling is involved in cognitive function and may represent a potential therapeutic target for cognitive dysfunction in patients with psychiatric disorders.

    DOI: 10.1016/j.bbr.2016.07.050

    Web of Science

    Scopus

    PubMed

    researchmap

  40. Deletion of JMJD2B in neurons leads to defective spine maturation, hyperactive behavior and memory deficits in mouse 査読有り

    Fujiwara, K; Fujita, Y; Kasai, A; Onaka, Y; Hashimoto, H; Okada, H; Yamashita, T

    TRANSLATIONAL PSYCHIATRY   6 巻 ( 3 ) 頁: e766   2016年3月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Translational Psychiatry  

    JMJD2B is a histone demethylase enzyme that regulates gene expression through demethylation of H3K9me3. Although mutations of JMJD2B have been suggested to be responsible for neurodevelopmental disorders, the function of JMJD2B in the central nervous system (CNS) remains to be elucidated. Here we show that JMJD2B has a critical role in the development of the CNS. We observed JMJD2B expression, which was especially strong in the hippocampus, throughout the CNS from embryonic periods through adulthood. We generated neuron-specific JMJD2B-deficient mice using the cre-loxP system. We found an increase in total spine number, but a decrease in mature spines, in the CA1 region of the hippocampus. JMJD2B-deficient mice exhibited hyperactive behavior, sustained hyperactivity in a novel environment, deficits in working memory and spontaneous epileptic-like seizures. Together these observations indicate that JMJD2B mutant mice display symptoms reminiscent of neurodevelopmental disorders. Our findings provide evidence for the involvement of histone demethylation in the formation of functional neural networks during development.

    DOI: 10.1038/tp.2016.31

    Web of Science

    Scopus

    PubMed

    researchmap

  41. Whole-exome sequencing and neurite outgrowth analysis in autism spectrum disorder 査読有り

    Hashimoto, R; Nakazawa, T; Tsurusaki, Y; Yasuda, Y; Nagayasu, K; Matsumura, K; Kawashima, H; Yamamori, H; Fujimoto, M; Ohi, K; Umeda-Yano, S; Fukunaga, M; Fujino, H; Kasai, A; Hayata-Takano, A; Shintani, N; Takeda, M; Matsumoto, N; Hashimoto, H

    JOURNAL OF HUMAN GENETICS   61 巻 ( 3 ) 頁: 199 - 206   2016年3月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Journal of Human Genetics  

    Autism spectrum disorder (ASD) is a complex group of clinically heterogeneous neurodevelopmental disorders with unclear etiology and pathogenesis. Genetic studies have identified numerous candidate genetic variants, including de novo mutated ASD-associated genes; however, the function of these de novo mutated genes remains unclear despite extensive bioinformatics resources. Accordingly, it is not easy to assign priorities to numerous candidate ASD-associated genes for further biological analysis. Here we developed a convenient system for identifying an experimental evidence-based annotation of candidate ASD-associated genes. We performed trio-based whole-exome sequencing in 30 sporadic cases of ASD and identified 37 genes with de novo single-nucleotide variations (SNVs). Among them, 5 of those 37 genes, POGZ, PLEKHA4, PCNX, PRKD2 and HERC1, have been previously reported as genes with de novo SNVs in ASD; and consultation with in silico databases showed that only HERC1 might be involved in neural function. To examine whether the identified gene products are involved in neural functions, we performed small hairpin RNA-based assays using neuroblastoma cell lines to assess neurite development. Knockdown of 8 out of the 14 examined genes significantly decreased neurite development (P<0.05, one-way analysis of variance), which was significantly higher than the number expected from gene ontology databases (P=0.010, Fisher's exact test). Our screening system may be valuable for identifying the neural functions of candidate ASD-associated genes for further analysis and a substantial portion of these genes with de novo SNVs might have roles in neuronal systems, although further detailed analysis might eliminate false positive genes from identified candidate ASD genes.

    DOI: 10.1038/jhg.2015.141

    Web of Science

    Scopus

    PubMed

    researchmap

  42. Myeloid cell-derived LRG attenuates adverse cardiac remodelling after myocardial infarction 査読有り

    Kumagai, S; Nakayama, H; Fujimoto, M; Honda, H; Serada, S; Ishibashi-Ueda, H; Kasai, A; Obana, M; Sakata, Y; Sawa, Y; Fujio, Y; Naka, T

    CARDIOVASCULAR RESEARCH   109 巻 ( 2 ) 頁: 272 - 282   2016年2月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Cardiovascular Research  

    Aims Leucine-rich α2-glycoprotein (LRG) is considered as a biomarker of the clinical activities of chronic inflammatory diseases, including heart failure. However, its pathophysiological roles in cardiac remodelling after myocardial infarction (MI) remain to be clarified. In this study, we have addressed functional roles of LRG in cardiac remodelling after MI. Methods and results MI was generated by ligating the left coronary artery in mice. Real-Time reverse transcription (RT)-PCR and immunoblot analyses revealed that the expressions of LRG transcript and protein were up-regulated in post-infarct myocardium. LRG protein was produced by heart-infiltrating myeloid cells, such as macrophages and neutrophils. To elucidate functional roles of LRG in cardiac remodelling, we generated MI in wild-Type (WT) and LRG-deficient (LRG-/-) mice and found that LRG gene ablation aggravated myocardial fibrosis with cardiac dysfunction after MI. Immunohistochemical analyses with anti-CD31 antibody revealed that capillary density decreased at border zone in LRG-/- mice compared with WT mice. Consistently, the expression of apelin receptor was reduced in LRG-/- mice, implying that the impaired angiogenic activity is associated with adverse cardiac remodelling in LRG-/- mice. Moreover, LRG gene ablation suppressed the activation of smad1/5/8, a pro-Angiogenic signalling pathway. Finally, the transplantation of WT bone marrow cells into LRG-/- mice attenuated cardiac fibrosis with functional improvement after MI, accompanied by restoration of capillary density compared with the bone marrow transplantation from LRG-/- mice. Conclusion LRG, produced by heart-infiltrating myeloid cells, suppresses adverse cardiac remodelling after MI as a novel cardioprotective factor. LRG signalling could be a therapeutic target against cardiovascular diseases.

    DOI: 10.1093/cvr/cvv273

    Web of Science

    Scopus

    PubMed

    researchmap

  43. Dopamine inhibits lipopolysaccharide-induced nitric oxide production through the formation of dopamine quinone in murine microglia BV-2 cells 査読有り

    Yoshioka, Y; Sugino, Y; Tozawa, A; Yamamuro, A; Kasai, A; Ishimaru, Y; Maeda, S

    JOURNAL OF PHARMACOLOGICAL SCIENCES   130 巻 ( 2 ) 頁: 51 - 59   2016年2月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Journal of Pharmacological Sciences  

    Dopamine (DA) has been suggested to modulate functions of glial cells including microglial cells. To reveal the regulatory role of DA in microglial function, in the present study, we investigated the effect of DA on lipopolysaccharide (LPS)-induced nitric oxide (NO) production in murine microglial cell line BV-2. Pretreatment with DA for 24 h concentration-dependently attenuated LPS-induced NO production in BV-2 cells. The inhibitory effect of DA on LPS-induced NO production was not inhibited by SCH-23390 and sulpiride, D1-like and D2-like DA receptor antagonists, respectively. In addition, pretreatment with (-)-(6aR,12bR)-4,6,6a,7,8,12b-Hexahydro-7-methylindolo[4,3-a]phenanthridin (CY 208-243) and bromocriptine, D1-like and D2-like DA receptor agonists, respectively, did not affect the LPS-induced NO production. N-Acetylcysteine, which inhibits DA oxidation, completely inhibited the effect of DA. Tyrosinase, which catalyzes the oxidation of DA to DA quionone (DAQ), accelerated the inhibitory effect of DA on LPS-induced NO production. These results suggest that DA attenuates LPS-induced NO production through the formation of DAQ in BV-2 cells.

    DOI: 10.1016/j.jphs.2015.11.002

    Web of Science

    Scopus

    PubMed

    researchmap

  44. De novo POGZ mutations in sporadic autism disrupt the DNA-binding activity of POGZ. 査読有り

    Matsumura K, Nakazawa T, Nagayasu K, Gotoda-Nishimura N, Kasai A, Hayata-Takano A, Shintani N, Yamamori H, Yasuda Y, Hashimoto R, Hashimoto H

    Journal of molecular psychiatry   4 巻   頁: 1   2016年

     詳細を見る

  45. Structured line illumination Raman microscopy 査読有り

    Watanabe, K; Palonpon, AF; Smith, NI; Chiu, LD; Kasai, A; Hashimoto, H; Kawata, S; Fujita, K

    NATURE COMMUNICATIONS   6 巻   頁: 10095   2015年12月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Nature Communications  

    In the last couple of decades, the spatial resolution in optical microscopy has increased to unprecedented levels by exploiting the fluorescence properties of the probe. At about the same time, Raman imaging techniques have emerged as a way to image inherent chemical information in a sample without using fluorescent probes. However, in many applications, the achievable resolution is limited to about half the wavelength of excitation light. Here we report the use of structured illumination to increase the spatial resolution of label-free spontaneous Raman microscopy, generating highly detailed spatial contrast from the ensemble of molecular information in the sample. Using structured line illumination in slit-scanning Raman microscopy, we demonstrate a marked improvement in spatial resolution and show the applicability to a range of samples, including both biological and inorganic chemical component mapping. This technique is expected to contribute towards greater understanding of chemical component distributions in organic and inorganic materials.

    DOI: 10.1038/ncomms10095

    Web of Science

    Scopus

    PubMed

    researchmap

  46. Comparative gene expression profiles in pancreatic islets associated with agouti yellow mutation and PACAP overexpression in mice 査読有り

    Ikeda K., Tomimoto S., Tsuchiya S., Hamagami K.I., Shintani N., Sugimoto Y., Ichikawa A., Kasai A., Nakazawa T., Nagayasu K., Hayata-Takano A., Baba A., Hashimoto H.

    Biochemistry and Biophysics Reports   2 巻   頁: 179 - 183   2015年7月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Biochemistry and Biophysics Reports  

    In diabetes mellitus, pituitary adenylate cyclase-activating polypeptide (PACAP) has insulinotropic and glucose-lowering properties. We previously demonstrated that transgenic mice overexpressing PACAP in pancreatic β-cells (PACAP-Tg) show attenuated pancreatic islet hyperplasia and hyperinsulinemia in type 2 diabetic models. To explore the underlying mechanisms, here we crossed PACAP-Tg mice with lethal yellow agouti (KKAy) diabetic mice, and performed gene chip analysis of laser capture microdissected pancreatic islets from four F1 offspring genotypes (wild-type, PACAP-Tg, KKAy, and PACAP-Tg:KKAy). We identified 1371 probes with >16-fold differences between at least one pair of genotypes, and classified the probes into five clusters with characteristic expression patterns. Gene ontology enrichment analysis showed that genes involved in the terms ribosome and intracellular organelles such as ribonucleoprotein complex, mitochondrion, and chromosome organization were significantly enriched in clusters characterized by up-regulated genes in PACAP-Tg:KKAy mice compared with KKAy mice. These results may provide insight into the mechanisms of diabetes that accompany islet hyperplasia and amelioration by PACAP.

    DOI: 10.1016/j.bbrep.2015.06.006

    Scopus

    PubMed

    researchmap

  47. ATOMOXETINE REVERSES LOCOMOTOR HYPERACTIVITY, IMPAIRED NOVEL OBJECT RECOGNITION, AND PREPULSE INHIBITION IMPAIRMENT IN MICE LACKING PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE 査読有り

    Shibasaki, Y; Hayata-Takano, A; Hazama, K; Nakazawa, T; Shintani, N; Kasai, A; Nagayasu, K; Hashimoto, R; Tanida, M; Katayama, T; Matsuzaki, S; Yamada, K; Taniike, M; Onaka, Y; Ago, Y; Waschek, JA; Köves, K; Reglödi, D; Tamas, A; Matsuda, T; Baba, A; Hashimoto, H

    NEUROSCIENCE   297 巻   頁: 95 - 104   2015年6月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Neuroscience  

    Attention-deficit/hyperactivity disorder (ADHD) is a complex neurobehavioral disorder that is characterized by attention difficulties, impulsivity, and hyperactivity. A non-stimulant drug, atomoxetine (ATX), which is a selective noradrenaline reuptake inhibitor, is widely used for ADHD because it exhibits fewer adverse effects compared to conventional psychostimulants. However, little is known about the therapeutic mechanisms of ATX. ATX treatment significantly alleviated hyperactivity of pituitary adenylate cyclase-activating polypeptide (PACAP)-deficient (PACAP<sup>-/-</sup>) mice with C57BL/6J and 129S6/SvEvTac hybrid background. ATX also improved impaired novel object recognition memory and prepulse inhibition in PACAP<sup>-/-</sup> mice with CD1 background. The ATX-induced increases in extracellular noradrenaline and dopamine levels were significantly higher in the prefrontal cortex of PACAP<sup>-/-</sup> mice compared to wild-type mice with C57BL/6J and 129S6/SvEvTac hybrid background. These results suggest that ATX treatment-induced increases in central monoamine metabolism may be involved in the rescue of ADHD-related abnormalities in PACAP<sup>-/-</sup> mice. Our current study suggests that PACAP<sup>-/-</sup> mice are an ideal rodent model with predictive validity for the study of ADHD etiology and drug development. Additionally, the potential effects of differences in genetic background of PACAP<sup>-/-</sup> mice on behaviors are discussed.

    DOI: 10.1016/j.neuroscience.2015.03.062

    Web of Science

    Scopus

    PubMed

    researchmap

  48. p13 overexpression in pancreatic β-cells ameliorates type 2 diabetes in high-fat-fed mice 査読有り

    Higashi, S; Katagi, K; Shintani, N; Ikeda, K; Sugimoto, Y; Tsuchiya, S; Inoue, N; Tanaka, S; Koumoto, M; Kasai, A; Nakazawa, T; Hayata-Takano, A; Hamagami, KI; Tomimoto, S; Yoshida, T; Ohkubo, T; Nagayasu, K; Ago, Y; Onaka, Y; Hashimoto, R; Ichikawa, A; Baba, A; Hashimoto, H

    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS   461 巻 ( 4 ) 頁: 612 - 617   2015年6月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Biochemical and Biophysical Research Communications  

    We examined the pancreatic function of p13 encoded by 1110001J03Rik, whose expression is decreased in pancreatic islets in high-fat-fed diabetic mice, by generating transgenic mice overexpressing p13 (p13-Tg) in pancreatic β-cells. p13-Tg mice showed normal basal glucose metabolism; however, under high-fat feeding, these animals showed augmented glucose-induced first-phase and total insulin secretion, improved glucose disposal, greater islet area and increased mitotic insulin-positive cells. In addition, high-fat diet-induced 4-hydroxynonenal immunoreactivity, a reliable marker and causative agent of lipid peroxidative stress, was significantly decreased in p13-Tg mouse islets. These results indicate that p13 is a novel pancreatic factor exerting multiple beneficial effects against type 2 diabetes.

    DOI: 10.1016/j.bbrc.2015.04.074

    Web of Science

    Scopus

    PubMed

    researchmap

  49. CRTH2, a prostaglandin D<sub>2</sub> receptor, mediates depression-related behavior in mice 査読有り

    Onaka, Y; Shintani, N; Nakazawa, T; Haba, R; Ago, Y; Wang, H; Kanoh, T; Hayata-Takano, A; Hirai, H; Nagata, K; Nakamura, M; Hashimoto, R; Matsuda, T; Waschek, JA; Kasai, A; Nagayasu, K; Baba, A; Hashimoto, H

    BEHAVIOURAL BRAIN RESEARCH   284 巻   頁: 131 - 137   2015年5月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Behavioural Brain Research  

    Depression is a complex neuropsychiatric disorder with an unclear molecular etiology. Inflammatory cytokines and molecular intermediates (including prostaglandins) are suggested to be involved in depression; however, the roles of prostaglandins and their respective receptors are largely unknown in depression. Using genetic and pharmacological approaches, we show here that chemoattractant receptor-homologous molecule expressed on T helper type 2 cells (CRTH2), a second receptor for prostaglandin D2 (PGD2), mediates depression-related behavior in mice. CRTH2-deficient (CRTH2-/-) mice showed antidepressant-like activity in a chronic corticosterone treatment-induced depression. Consistent with this observation, the pharmacological inhibition of CRTH2 via the clinically available drug ramatroban also rescued abnormal social interaction and depression-related behavior in well-established models, including chronic corticosterone-, lipopolysaccharide-, and tumor-induced pathologically relevant depression models. Importantly, chronic stress via corticosterone treatment increased mRNA levels in PGD2-producing enzymes, such as cyclooxygenase-2 and lipocalin-type PGD2 synthase, in the brain. Furthermore, the activity of the hippocampal noradrenergic system but not the dopaminergic or serotonergic systems was increased in CRTH2-/- mice. Together with the observation that untreated CRTH2-/- mice showed antidepressant-like activity in the forced swim test, these results provide evidence that central CRTH2-mediated signaling is critically involved in depression-related behavior.

    DOI: 10.1016/j.bbr.2015.02.013

    Web of Science

    Scopus

    PubMed

    researchmap

  50. A Mouse Model of Human Primitive Neuroectodermal Tumors Resulting from Microenvironmentally-Driven Malignant Transformation of Orthotopically Transplanted Radial Glial Cells 査読有り

    Malchenko, S; Sredni, ST; Hashimoto, H; Kasai, A; Nagayasu, K; Xie, JP; Margaryan, NV; Seiriki, K; Lulla, RR; Seftor, REB; Pachman, LM; Meltzer, HY; Hendrix, MJC; Soares, MB

    PLOS ONE   10 巻 ( 3 ) 頁: e0121707   2015年3月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:PLoS ONE  

    There is growing evidence and a consensus in the field that most pediatric brain tumors originate from stem cells, of which radial glial cells constitute a subtype. Here we show that orthotopic transplantation of human radial glial (RG) cells to the subventricular zone of the 3rd ventricle - but not to other transplantation sites - of the brain in immunocompromised NOD-SCID mice, gives rise to tumors that have the hallmarks of CNS primitive neuroectodermal tumors (PNETs). The resulting mouse model strikingly recapitulates the phenotype of PNETs. Importantly, the observed tumorigenic transformation was accompanied by aspects of an epithelial to mesenchymal transition (EMT)-like process. It is also noteworthy that the tumors are highly invasive, and that they effectively recruit mouse endothelial cells for angiogenesis. These results are significant for several reasons. First, they show that malignant transformation of radial glial cells can occur in the absence of specific mutations or inherited genomic alterations. Second, they demonstrate that the same radial glial cells may either give rise to brain tumors or differentiate normally depending upon the microenvironment of the specific region of the brain to which the cells are transplanted. In addition to providing a prospect for drug screening and development of new therapeutic strategies, the resulting mouse model of PNETs offers an unprecedented opportunity to identify the cancer driving molecular alterations and the microenvironmental factors that are responsible for committing otherwise normal radial glial cells to a malignant phenotype.

    DOI: 10.1371/journal.pone.0121707

    Web of Science

    Scopus

    PubMed

    researchmap

  51. PACAP Enhances Axon Outgrowth in Cultured Hippocampal Neurons to a Comparable Extent as BDNF 査読有り

    Ogata, K; Shintani, N; Hayata-Takano, A; Kamo, T; Higashi, S; Seiriki, K; Momosaki, H; Vaudry, D; Vaudry, H; Galas, L; Kasai, A; Nagayasu, K; Nakazawa, T; Hashimoto, R; Ago, Y; Matsuda, T; Baba, A; Hashimoto, H

    PLOS ONE   10 巻 ( 3 ) 頁: e0120526   2015年3月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:PLoS ONE  

    Pituitary adenylate cyclase-activating polypeptide (PACAP) exerts neurotrophic activities including modulation of synaptic plasticity and memory, hippocampal neurogenesis, and neuroprotection, most of which are shared with brain-derived neurotrophic factor (BDNF). Therefore, the aim of this study was to compare morphological effects of PACAP and BDNF on primary cultured hippocampal neurons. At days in vitro (DIV) 3, PACAP increased neurite length and number to similar levels by BDNF, but vasoactive intestinal polypeptide showed much lower effects. In addition, PACAP increased axon, but not dendrite, length, and soma size at DIV 3 similarly to BDNF. The PACAP antagonist PACAP6-38 completely blocked the PACAP-induced increase in axon, but not dendrite, length. Interestingly, the BDNF-induced increase in axon length was also inhibited by PACAP6-38, suggesting a mechanism involving PACAP signaling. K252a, a TrkB receptor inhibitor, inhibited axon outgrowth induced by PACAP and BDNF without affecting dendrite length. These results indicate that in primary cultured hippocampal neurons, PACAP shows morphological actions via its cognate receptor PAC1, stimulating neurite length and number, and soma size to a comparable extent as BDNF, and that the increase in total neurite length is ascribed to axon outgrowth.

    DOI: 10.1371/journal.pone.0120526

    Web of Science

    Scopus

    PubMed

    researchmap

  52. Simultaneous neuron- and astrocyte-specific fluorescent marking 査読有り

    Schulze, W; Hayata-Takano, A; Kamo, T; Nakazawa, T; Nagayasu, K; Kasai, A; Seiriki, K; Shintani, N; Ago, Y; Farfan, C; Hashimoto, R; Baba, A; Hashimoto, H

    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS   459 巻 ( 1 ) 頁: 81 - 86   2015年3月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Biochemical and Biophysical Research Communications  

    Systematic and simultaneous analysis of multiple cell types in the brain is becoming important, but such tools have not yet been adequately developed. Here, we aimed to generate a method for the specific fluorescent labeling of neurons and astrocytes, two major cell types in the brain, and we have developed lentiviral vectors to express the red fluorescent protein tdTomato in neurons and the enhanced green fluorescent protein (EGFP) in astrocytes. Importantly, both fluorescent proteins are fused to histone 2B protein (H2B) to confer nuclear localization to distinguish between single cells. We also constructed several expression constructs, including a tandem alignment of the neuron- and astrocyte-expression cassettes for simultaneous labeling. Introducing these vectors and constructs in vitro and in vivo resulted in cell type-specific and nuclear-localized fluorescence signals enabling easy detection and distinguishability of neurons and astrocytes. This tool is expected to be utilized for the simultaneous analysis of changes in neurons and astrocytes in healthy and diseased brains.

    DOI: 10.1016/j.bbrc.2015.02.073

    Web of Science

    Scopus

    PubMed

    researchmap

  53. Identification of the role of bone morphogenetic protein (BMP) and transforming growth factor-β (TGF-β) signaling in the trajectory of serotonergic differentiation in a rapid assay in mouse embryonic stem cells <i>in vitro</i> 査読有り

    Yamasaki, A; Kasai, A; Toi, A; Kurita, M; Kimoto, S; Hayata-Takano, A; Nakazawa, T; Nagayasu, K; Shintani, N; Hashimoto, R; Ito, A; Meltzer, HY; Ago, Y; Waschek, JA; Onaka, Y; Matsuda, T; Baba, A; Hashimoto, H

    JOURNAL OF NEUROCHEMISTRY   132 巻 ( 4 ) 頁: 418 - 428   2015年2月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Journal of Neurochemistry  

    The mechanism by which extracellular molecules control serotonergic cell fate remains elusive. Recently, we showed that noggin, which inactivates bone morphogenetic proteins (BMPs), induces serotonergic differentiation of mouse embryonic (ES) and induced pluripotent stem cells with coordinated gene expression along the serotonergic lineage. Here, we created a rapid assay for serotonergic induction by generating knock-in ES cells expressing a naturally secreted Gaussia luciferase driven by the enhancer of Pet-1/Fev, a landmark of serotonergic differentiation. Using these cells, we performed candidate-based screening and identified BMP type I receptor kinase inhibitors LDN-193189 and DMH1 as activators of luciferase. LDN-193189 induced ES cells to express the genes encoding Pet-1, tryptophan hydroxylase 2, and the serotonin transporter, and increased serotonin release without altering dopamine release. In contrast, TGF-β receptor inhibitor SB-431542 selectively inhibited serotonergic differentiation, without changing overall neuronal differentiation. LDN-193189 inhibited expression of the BMP signaling target gene Id, and induced the TGF-β target gene Lefty, whereas the opposite effect was observed with SB-431542. This study thus provides a new tool to investigate serotonergic differentiation and suggests that inhibition of BMP type I receptors and concomitant activation of TGF-β receptor signaling are implicated in serotonergic differentiation.

    DOI: 10.1111/jnc.12999

    Web of Science

    Scopus

    PubMed

    researchmap

  54. Enhancement of the lateral resolution of Raman microscopy by use of structured illumination 査読有り

    Palonpon A.F., Watanabe K., Smith N.I., Chiu L.D., Kasai A., Hashimoto H., Kawata S., Fujita K.

    Optics InfoBase Conference Papers   Part F132-JSAP 2019 巻   2015年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(国際会議プロシーディングス)   出版者・発行元:Optics InfoBase Conference Papers  

    Recent developments in optical microscopy especially fluorescence microscopy have pushed the limits of spatial resolution below the diffraction limit, to as low as several nanometers. Most of these super-resolution techniques, however, cannot be adapted to Raman microscopy because their working principle is based on manipulating the fluorescence emission properties of the sample. On the other hand, structured illumination microscopy (SIM) utilizes the Moire effect (interference of the structured light pattern with the sample structure) to double the spatial resolution [1] and therefore does not impose particular optical properties on the sample, making it a feasible technique for Raman microscopy.

    Scopus

    researchmap

  55. Increased Behavioral and Neuronal Responses to a Hallucinogenic Drug in PACAP Heterozygous Mutant Mice 査読有り

    Hazama, K; Hayata-Takano, A; Uetsuki, K; Kasai, A; Encho, N; Shintani, N; Nagayasu, K; Hashimoto, R; Reglodi, D; Miyakawa, T; Nakazawa, T; Baba, A; Hashimoto, H

    PLOS ONE   9 巻 ( 2 ) 頁: e89153   2014年2月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:PLoS ONE  

    Accumulating evidence from human genetic studies implicates the pituitary adenylate cyclase-activating polypeptide (PACAP) gene as a risk factor for psychiatric disorders, including schizophrenia and stress-related diseases. Mice with homozygous disruption of the PACAP gene display profound behavioral and neurological abnormalities that are ameliorated with the atypical antipsychotic and dopamine D2 and serotonin (5-HT)2 antagonist risperidone and the 5-HT2 receptor antagonist ritanserin; however, the underlying mechanisms remain unknown. Here, we investigated if PACAP heterozygous mutant (PACAP+/-) mice, which appear behaviorally normal, are vulnerable to aversive stimuli. PACAP+/- mice were administered a 5-HT2 receptor agonist, (±)-2,5-dimethoxy-4- iodoamphetamine (DOI), a hallucinogenic drug, and their responses were compared with the littermate wild-type mice. After DOI injection, PACAP+/- mice showed increased head-twitch responses, while their behavior was normal after saline. DOI induced deficits in sensorimotor gating, as determined by prepulse inhibition, specifically in PACAP+/- mice. However, other 5-HT2 receptor-dependent responses, such as corticosterone release and hypothermia, were similarly observed in PACAP+/- and wild-type mice. c-Fos expression analysis, performed in various brain regions, revealed that the DOI-induced increase in the number of c-Fos-positive cells was more pronounced in 5-HT2A receptor-negative cells in the somatosensory cortex in PACAP+/- mice compared with wild-type mice. These results indicate that PACAP+/- mice exhibit specific vulnerability to DOI-induced deficits in cortical sensory function, such as exaggerated head-twitch responses and sensorimotor gating deficits. Our findings provide insight into the neural mechanisms underlying impaired behavioral responses in which 5-HT2 receptors are implicated. © 2014 Hazama et al.

    DOI: 10.1371/journal.pone.0089153

    Web of Science

    Scopus

    PubMed

    researchmap

  56. Central CRTH2, a Second Prostaglandin D<sub>2</sub> Receptor, Mediates Emotional Impairment in the Lipopolysaccharide and Tumor-Induced Sickness Behavior Model 査読有り

    Haba, R; Shintani, N; Onaka, Y; Kanoh, T; Wang, H; Takenaga, R; Hayata, A; Hirai, H; Nagata, K; Nakamura, M; Kasai, A; Hashimoto, R; Nagayasu, K; Nakazawa, T; Hashimoto, H; Baba, A

    JOURNAL OF NEUROSCIENCE   34 巻 ( 7 ) 頁: 2514 - 2523   2014年2月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Journal of Neuroscience  

    Chemoattractant receptor-homologous molecule expressed on T helper type 2 cells (CRTH2) is a second prostaglandin D2 receptor involved in mediating the allergic response; however, its central function is not yet known. Here, we demonstrate that central CRTH2 mediates emotional impairment. Lipopolysaccharide (LPS)-induced decreases in social interaction and novel exploratory behavior were observed in wild-type (CRTH2+/+) mice but not CRTH2-deficient (CRTH2-/-) mice, but both genotypes showed hypolocomotion and anorexia following LPS injection. Tumor (colon 26) inoculation, a more pathologically relevant model, induced decreases in social interaction and novel exploratory behavior in CRTH2+/+, but not CRTH2-/- mice. In addition, the CRTH2 antagonists including clinically available ramatroban reversed impaired social interaction and novel exploratory behavior after either LPS or tumor inoculation in CRTH2+/+ mice. Finally, LPS-induced c-Fos expression in the hypothalamic paraventricular nucleus (PVN) and central amygdala (CeA) was selectively abolished in CRTH2-/- mice. These results show that CRTH2 participates in LPS-induced emotional changes and activation in the PVN and CeA. Our study provides the first evidence that central CRTH2 regulates specific emotional behaviors, and that CRTH2 antagonism has potential as a therapeutic target for behavioral symptoms associated with tumors and infectious diseases. © 2014 the authors.

    DOI: 10.1523/JNEUROSCI.1407-13.2014

    Web of Science

    Scopus

    PubMed

    researchmap

  57. Targeted STAT3 disruption in myeloid cells alters immunosuppressor cell abundance in a murine model of spontaneous medulloblastoma 査読有り

    Abad, C; Nobuta, H; Li, JX; Kasai, A; Yong, WH; Waschek, JA

    JOURNAL OF LEUKOCYTE BIOLOGY   95 巻 ( 2 ) 頁: 357 - 367   2014年2月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1189/jlb.1012531

    Web of Science

    PubMed

    researchmap

  58. Inhibition of apelin expression switches endothelial cells from proliferative to mature state in pathological retinal angiogenesis 査読有り

    Kasai, A; Ishimaru, Y; Higashino, K; Kobayashi, K; Yamamuro, A; Yoshioka, Y; Maeda, S

    ANGIOGENESIS   16 巻 ( 3 ) 頁: 723 - 734   2013年7月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Angiogenesis  

    The recruitment of mural cells such as pericytes to patent vessels with an endothelial lumen is a key factor for the maturation of blood vessels and the prevention of hemorrhage in pathological angiogenesis. To date, our understanding of the specific trigger underlying the transition from cell growth to the maturation phase remains incomplete. Since rapid endothelial cell growth causes pericyte loss, we hypothesized that suppression of endothelial growth factors would both promote pericyte recruitment, in addition to inhibiting pathological angiogenesis. Here, we demonstrate that targeted knockdown of apelin in endothelial cells using siRNA induced the expression of monocyte chemoattractant protein-1 (MCP-1) through activation of Smad3, via suppression of the PI3K/Akt pathway. The conditioned medium of endothelial cells treated with apelin siRNA enhanced the migration of vascular smooth muscle cells, through MCP-1 and its receptor pathway. Moreover, in vivo delivery of siRNA targeting apelin, which causes exuberant endothelial cell proliferation and pathological angiogenesis through its receptor APJ, led to increased pericyte coverage and suppressed pathological angiogenesis in an oxygen-induced retinopathy model. These data demonstrate that apelin is not only a potent endothelial growth factor, but also restricts pericyte recruitment, establishing a new connection between endothelial cell proliferation signaling and a trigger of mural recruitment. © 2013 The Author(s).

    DOI: 10.1007/s10456-013-9349-6

    Web of Science

    Scopus

    PubMed

    researchmap

  59. Laser-Induced Choroidal Neovascularization in Mice Attenuated by Deficiency in the Apelin-APJ System 査読有り

    Hara, C; Kasai, A; Gomi, F; Satooka, T; Sakimoto, S; Nakai, K; Yoshioka, Y; Yamamuro, A; Maeda, S; Nishida, K

    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE   54 巻 ( 6 ) 頁: 4321 - 4329   2013年6月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Investigative Ophthalmology and Visual Science  

    PURPOSE. To investigate the role of the apelin-APJ system in the development of choroidal neovascularization (CNV). METHODS. Experimental CNV was induced by laser photocoagulation in wild-type (WT), apelin-deficient (apelin-KO), and apelin receptor (APJ)-deficient (APJ-KO) mice. The gene expression levels of angiogenic or inflammatory factors were determined by quantitative realtime reverse transcription-polymerase chain reaction. APJ expression in CNV lesions was examined by immunohistochemistry. The sizes of the CNV lesions in the three mouse models were measured and compared histologically using isolectin B4 staining. Macrophage recruitment was measured by flow cytometric analysis. Proliferation of endothelial cells was determined using the alamar Blue assay. RESULTS. Laser photocoagulation significantly increased expression of apelin and APJ in the retina-retinal pigment epithelium (RPE) complex. APJ immunoreactive cells were found in the CNV lesions and colocalized with platelet endothelial cell adhesion molecule-1, an endothelial cell marker. The sizes of the CNV lesions in apelin-KO or APJ-KO mice decreased significantly compared with those in the WT mice. Macrophages in the RPE complex of the apelin-KO mice, in which gene expression of the inflammatory factors was almost equal to that in WT mice, were recruited as a result of laser photocoagulation to the same degree as in WT mice. In addition, apelin small and interfering RNA (siRNA) suppressed proliferation of endothelial cells independently of vascular endothelial growth factor (VEGF) receptor 2 signaling, while VEGF increased expression of apelin and APJ in human umbilical vein endothelial cells. CONCLUSIONS. The results suggested that the apelin-APJ system contributes to CNV development partially independent of the VEGF pathway. © 2013 The Association for Research in Vision and Ophthalmology, Inc.

    DOI: 10.1167/iovs.13-11611

    Web of Science

    Scopus

    PubMed

    researchmap

  60. [Apelin-APJ system: from discovery to therapeutic target]. 査読有り

    Kasai A

    Nihon yakurigaku zasshi. Folia pharmacologica Japonica   139 巻 ( 5 ) 頁: 198 - 202   2012年5月

     詳細を見る

    記述言語:日本語   出版者・発行元:5  

    近年,ヒトや他の動物種の遺伝子配列が解読され,それに伴い新たなGタンパク質共役型受容体(GPCR)が発見され,これらの大部分が内因性のリガンドが不明なオーファンGPCRであることが明らかになってきた.本稿では,その中の一つで1998年に脱オーファン化したGタンパク質共役型受容体APJとその内因性リガンドであるアペリンのこれまでの研究について概説する.アペリンは13アミノ酸からなるペプチドで,その配列はマウスからヒトまで保存されている.APJはアンジオテンシンII受容体AT1とヘテロダイマーを形成することでアンジオテンシンIIの血圧上昇作用を阻害する内因性の拮抗システムとして機能していることが示されている.その他,アペリン–APJシステムは,血管内皮細胞に対し強力な増殖作用を示し,様々な生理的な血管形成および,病態時の血管新生に関与していることが明らかになってきた.さらに,既存の血管内皮増殖因子(VEGF)によりAPJの発現が,塩基性繊維芽細胞増殖因子(FGF2)やアンジオポエチン/Tie2システムによりアペリンの発現がそれぞれ上昇することから,既存の主要な血管新生因子とのクロストークが示されている.一方で,細胞内シグナルでは,VEGFなどのPKC/Raf/MEK経路とは独立してAkt/mTOR/p70S6キナーゼを介して細胞増殖作用を示すことが報告されている.また,アペリンは低酸素に誘導されることや,糖尿病網膜症などのマウスモデルにおいて発現上昇が生理的な血管形成時よりも劇的に高いことから,虚血性血管新生が関与する病態形成に強く関与することが考えられる.これらの疾患では抗VEGF中和抗体が臨床応用され始めたが,それに伴いいくつかの問題点が挙げられている.そのためVEGFシグナルとは独立した経路を持つアペリン–APJシステムを標的とした新規治療薬がこの問題点を解決できる可能性が考えられる.

    DOI: 10.1254/fpj.139.198

    PubMed

    CiNii Books

    researchmap

    その他リンク: https://jlc.jst.go.jp/DN/JALC/10000262803?from=CiNii

  61. Performance of cell-penetrating peptide-linked polymers physically mixed with poorly membrane-permeable molecules on cell membranes 査読有り

    Sakuma, S; Suita, M; Yamamoto, T; Masaoka, Y; Kataoka, M; Yamashita, S; Nakajima, N; Shinkai, N; Yamauchi, H; Hiwatari, K; Hashizume, A; Tachikawa, H; Kimura, R; Ishimaru, Y; Kasai, A; Maeda, S

    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS   81 巻 ( 1 ) 頁: 64 - 73   2012年5月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1016/j.ejpb.2012.01.008

    Web of Science

    PubMed

    researchmap

  62. レーザー誘発性脈絡膜新生血管におけるapelin/APJシグナルの関与 査読有り

    上野 千佳子, 笠井 淳司, 五味 文, 里岡 達哉, 中井 慶, 山室 晶子, 西田 幸二

    日本眼科学会雑誌   116 巻 ( 臨増 ) 頁: 340 - 340   2012年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公財)日本眼科学会  

    researchmap

  63. Apelin Deficiency Accelerates the Progression of Amyotrophic Lateral Sclerosis 査読有り

    Kasai, A; Kinjo, T; Ishihara, R; Sakai, I; Ishimaru, Y; Yoshioka, Y; Yamamuro, A; Ishige, K; Ito, Y; Maeda, S

    PLOS ONE   6 巻 ( 8 ) 頁: e23968   2011年8月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1371/journal.pone.0023968

    Web of Science

    PubMed

    researchmap

  64. Pathological Role of Apelin in Angiogenic Eye Disease 査読有り

    Atsushi Kasai

    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN   131 巻 ( 8 ) 頁: 1201 - 1206   2011年8月

     詳細を見る

    記述言語:日本語   出版者・発行元:PHARMACEUTICAL SOC JAPAN  

    Progression of ischemic retinal diseases, such as diabetic retinopathy, is closely associated with pathological retinal angiogenesis mainly induced by vascular endothelial growth factor (VEGF). Anti-angiogenic therapy using anti-VEGF antibodies is effective in treating diabetic retinopathy, even though its efficacy is not long-lasting. Since many factors are involved in angiogenesis, it is reasonable to seek new therapeutic target molecules in pathological retinal angiogenesis. We have found that apelin/APJ system is involved in not only physiological but also pathological retinal angiogenesis using a mouse model of oxygen-induced retinopathy (OIR). Oxygen-induced vessel loss in the retinas of OIR model leads to a significant increase in the capillary density accompanied by abnormal vessel growth, similar to aneurysms, which are hardly detected in the retinas of control mice. Compared with age-matched control mice, retinal apelin expression was dramatically increased during retinal angiogenesis in OIR model. Immunostaining for APJ, apelin receptor, in retinal from OIR model revealed that APJ was localized in proliferating endothelial cells in the retinal vascular plexus. Retinal angiogenesis in the OIR model was rarely observed in apelin deficient mice, although temporal expression pattern of VEGF was similar to that of wild-type OIR model. In addition, clinical study showed that vitreous concentrations of apelin were significantly higher in the proliferative diabetic retinopathy group than in the control group. Taken together, these findings clearly suggest that apelin/APJ system may be a crucial factor for pathological retinal angiogenesis. Inhibition of this system could offer new therapeutic opportunities against ischemic retinopathy.

    DOI: 10.1248/yakushi.131.1201

    Web of Science

    PubMed

    researchmap

  65. Caspase-4 Directly Activates Caspase-9 in Endoplasmic Reticulum Stress-Induced Apoptosis in SH-SY5Y Cells 査読有り

    Yamamuro, A; Kishino, T; Ohshima, Y; Yoshioka, Y; Kimura, T; Kasai, A; Maeda, S

    JOURNAL OF PHARMACOLOGICAL SCIENCES   115 巻 ( 2 ) 頁: 239 - 243   2011年2月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1254/jphs.10217SC

    Web of Science

    PubMed

    researchmap

  66. Phenotypic Characterization of Transgenic Mice Overexpressing Neuregulin-1 査読有り

    Kato, T; Kasai, A; Mizuno, M; Liang, FY; Shintani, N; Maeda, S; Yokoyama, M; Ozaki, M; Nawa, H

    PLOS ONE   5 巻 ( 12 ) 頁: e14185   2010年12月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:PLoS ONE  

    Background: Neuregulin-1 (NRG1) is one of the susceptibility genes for schizophrenia and implicated in the neurotrophic regulation of GABAergic and dopaminergic neurons, myelination, and NMDA receptor function. Postmortem studies often indicate a pathologic association of increased NRG1 expression or signaling with this illness. However, the psychobehavioral implication of NRG1 signaling has mainly been investigated using hypomorphic mutant mice for individual NRG1 splice variants. Methodology/Principal Findings: To assess the behavioral impact of hyper NRG1 signaling, we generated and analyzed two independent mouse transgenic (Tg) lines carrying the transgene of green fluorescent protein (GFP)-tagged type-1 NRG1 cDNA. The promoter of elongation-factor 1α gene drove ubiquitous expression of GFP-tagged NRG1 in the whole brain. As compared to control littermates, both heterozygous NRG1-Tg lines showed increased locomotor activity, a nonsignificant trend toward decreasing prepulse inhibition, and decreased context-dependent fear learning but exhibited normal levels of tone-dependent learning. In addition, social interaction scores in both Tg lines were reduced in an isolationinduced resident-intruder test. There were also phenotypic increases in a GABAergic marker (parvalbumin) as well as in myelination markers (myelin basic protein and 2′,3′-cyclic nucleotide 3′-phosphodiesterase) in their frontal cortex, indicating the authenticity of NRG1 hyper-signaling, although there were marked decreases in tyrosine hydroxylase levels and dopamine content in the hippocampus. Conclusions: These findings suggest that aberrant hyper-signals of NRG1 also disrupt various cognitive and behavioral processes. Thus, neuropathological implication of hyper NRG1 signaling in psychiatric diseases should be evaluated with further experimentation. © 2010 Kato et al.

    DOI: 10.1371/journal.pone.0014185

    Web of Science

    Scopus

    PubMed

    researchmap

  67. Apelin Is a Crucial Factor for Hypoxia-Induced Retinal Angiogenesis 査読有り

    Kasai, A; Ishimaru, Y; Kinjo, T; Satooka, T; Matsumoto, N; Yoshioka, Y; Yamamuro, A; Gomi, F; Shintani, N; Baba, A; Maeda, S

    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY   30 巻 ( 11 ) 頁: 2182 - U361   2010年11月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Arteriosclerosis, Thrombosis, and Vascular Biology  

    OBJECTIVE-: To investigate the role of endogenous apelin in pathological retinal angiogenesis. METHODS AND RESULTS-: The progression of ischemic retinal diseases, such as diabetic retinopathy, is closely associated with pathological retinal angiogenesis, mainly induced by vascular endothelial growth factor (VEGF) and erythropoietin. Although antiangiogenic therapies using anti-VEGF drugs are effective in treating retinal neovascularization, they show a transient efficacy and cause general adverse effects. New therapeutic target molecules are needed to resolve these issues. It was recently demonstrated that the apelin/APJ system, a newly deorphanized G protein-coupled receptor system, is involved in physiological retinal vascularization. Retinal angiography and mRNA expression were examined during hypoxia-induced retinal angiogenesis in a mouse model of oxygen-induced retinopathy. Compared with age-matched control mice, retinal apelin expression was dramatically increased during the hypoxic phase in oxygen-induced retinopathy model mice. APJ was colocalized in proliferative cells, which were probably endothelial cells of the ectopic vessels in the vitreous body. Apelin deficiency hardly induced hypoxia-induced retinal angiogenesis despite the upregulation of VEGF and erythropoietin mRNA in oxygen-induced retinopathy model mice. Apelin small and interfering RNA suppressed the proliferation of endothelial cells independent of the VEGF/VEGF receptor 2 signaling pathway. CONCLUSION-: These results suggest that apelin is a prerequisite factor for hypoxia-induced retinal angiogenesis. © 2010 American Heart Association, Inc.

    DOI: 10.1161/ATVBAHA.110.209775

    Web of Science

    Scopus

    PubMed

    researchmap

  68. Nitric Oxide Inhibits Lipopolysaccharide-Induced Inducible Nitric Oxide Synthase Expression and Its Own Production Through the cGMP Signaling Pathway in Murine Microglia BV-2 Cells 査読有り

    Yoshioka, Y; Takeda, N; Yamamuro, A; Kasai, A; Maeda, S

    JOURNAL OF PHARMACOLOGICAL SCIENCES   113 巻 ( 2 ) 頁: 153 - 160   2010年6月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1254/jphs.10060FP

    Web of Science

    PubMed

    researchmap

  69. Apelin is a crucial factor for hypoxia-induced retinal angiogenesis 査読有り

    笠井 淳司

    Arteriosclerosis, Thrombosis, and Vascular Biology   30 巻   頁: 2182 - 2187   2010年

     詳細を見る

    担当区分:筆頭著者, 責任著者   記述言語:英語  

    CiNii Research

  70. Retardation of retinal vascular development in apelin-deficient mice 査読有り

    Kasai, A; Shintani, N; Kato, H; Matsuda, S; Gomi, F; Haba, R; Hashimoto, H; Kakuda, M; Tano, Y; Baba, A

    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY   28 巻 ( 10 ) 頁: 1717 - 1722   2008年10月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Arteriosclerosis, Thrombosis, and Vascular Biology  

    Objective - Apelin is an endogenous ligand for the G protein-coupled receptor, APJ, and participates in multiple physiological processes. To identify the roles of endogenous apelin, we investigated the phenotype of apelin-deficient (apelin-KO) mice. Methods and Results - Apelin-KO mice showed impaired retinal vascularization and ocular development, which were analyzed by histology, immunohistochemistry, real-time polymerase chain reaction, and the mouse corneal micropocket assay. Apelin-KO mice showed significantly impaired retinal vascularization in the early postnatal period. Retinal apelin/APJ mRNAs were transiently upregulated during the first 2 postnatal weeks but were undetectable in adults. There were no differences in VEGF or FGF2 mRNA expression, or in the morphology and localization of GFAP-positive astrocytes, in the apelin-KO retinas at P5. The corneal pocket assay showed that angiogenic responses to VEGF and FGF2 were remarkably decreased in apelin-KO mice. The reduced responses to VEGF and FGF2 in apelin-KO mice were partially restored by apelin, but apelin alone did not induce angiogenesis. Conclusions - Our results suggest that spatiotemporally regulated apelin/APJ signaling participates in retinal vascularization in a cooperative manner with VEGF or FGF2, and contributes to normal ocular development. © 2008 American Heart Association, Inc.

    DOI: 10.1161/ATVBAHA.108.163402

    Web of Science

    Scopus

    PubMed

    researchmap

  71. [First screening for behavioral phenotype of gene-engineered mice]. 査読有り

    Kasai A, Shintani N

    Nihon yakurigaku zasshi. Folia pharmacologica Japonica   130 巻 ( 4 ) 頁: 281 - 285   2007年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:4  

    ヒトゲノム解読の完了や科学技術の進歩により,生体内において様々な機能未知分子が同定されるようになってきた.これら分子の生理・病態的役割の解明において,分子に対する特異的作用薬(作動薬・拮抗薬)がない場合,当該分子あるいはその機能発現に関わる分子群の遺伝子改変動物,特に遺伝子改変マウスの表現型解析からのアプローチが有用とされている.本研究手法は,マウスの表現型異常の原因を遺伝子の改変に帰することができることから,異常が認められた表現型と遺伝子との直接的因果関連を実証できるだけでなく,予想外の表現型の同定によって,当該遺伝子の新規機能を導き出せる可能性を秘めている.しかし,従来の表現型解析では,主に目的とする表現型のみに注目した研究がなされ,他の表現型が無視される傾向にあったことや,表現型解析を行う場合には多くの実験装置や熟練した技術が必要であることなど,いくつかの問題点があった.これらを考慮し,簡易かつ迅速に遺伝子改変マウスの表現型を抽出し,網羅的に解析する方法として考案されたのがSHIRPA法である.本法は,三段階のスクリーニング系からなり,特に一次スクリーニングは遺伝子改変マウスの行動学的表現型を迅速に評価できる方法として有用である.本稿では,神経ペプチドPACAP(pituitary adenylate cyclase-activating polypeptide)の遺伝子欠損マウス(PACAP-KO)における解析結果を例に,SHIRPA一次スクリーニング法の利用の実際を紹介する.<br>

    DOI: 10.1254/fpj.130.281

    PubMed

    CiNii Books

    researchmap

    その他リンク: https://jlc.jst.go.jp/DN/JALC/00300745410?from=CiNii

▼全件表示

MISC 42

  1. Trans-scale-scope to find rare cellular activity in sub-million cells

    Taro Ichimura, Taishi Kakizuka, Kazuki Horikawa, Kaoru Seiriki, Atsushi Kasai, Hitoshi Hashimoto, Katsumasa Fujita, Tomonobu M. Watanabe, Takeharu Nagai  

        2020年6月

     詳細を見る

    出版者・発行元:Cold Spring Harbor Laboratory  

    <title>Abstract</title>There are many phenomena in biological systems where less than 1% of rare cells trigger entire multicellular systems. In order to scientifically understand the mechanisms of these rare cell-driven systems, simultaneous observation of huge populations of cells is essential. It has been difficult to observe the dynamics of such phenomena with conventional microscopes. In this study, we propose a novel type of imager, trans-scale-scope, which allows us to observe cell dynamics with sub-cell resolution in a field of view greater than a centimeter. The imaging system is mainly composed of a hundred-megapixel image sensor and a macro-lens for full-size sensor. This method, which is the basement of the future imaging system named AMATERAS (A Multi-scale/modal Analytical Tool for Every Rare Activity in Singularity), realized observation of sub-million cells at the same time. By observing the macroscale-pattern formation process of <italic>Dictyostelium discoideum</italic>, a model organism for studying fundamental aspects of cell-cell communication and chemotaxis, we have shown that the 0.1 % of rare cells triggered a stream of collective cell migration.

    DOI: 10.1101/2020.06.29.179044

    researchmap

  2. High-resolution imaging of primate brains using FAST

    Hashimoto H, Seiriki K, Kasai A, Nakazawa T, Inoue K, Takada M  

    International Workshop "Monitoring and manipulating brain function in non-human primates"(2018/7/31, 千葉市)   2018年7月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)  

    researchmap

  3. 全脳イメージング法を用いた精神疾患モデルマウスの機能評価 招待有り

    勢力 薫, 笠井 淳司, 橋本 均  

    日本生物学的精神医学会誌29 巻 ( 1 ) 頁: 22 - 26   2018年3月

     詳細を見る

    記述言語:日本語  

    researchmap

  4. FAST, High-speed serial-sectioning imaging for whole brain analysis with high scalability.

    Kasai A, Seiriki K, Hashimoto T, Niu M, Yamaguchi S, Naka Y, Igarashi H, Tamura M, Nakazawa T, Inoue K, Takada M, Fujita K, Hashimoto H  

    Neuroscience 2017(2017/11/13,Washington, DC, USA)   2017年11月

     詳細を見る

    記述言語:英語  

    researchmap

  5. 全脳マッピングと神経活動操作による情動行動制御機構の解明

    笠井 淳司, 丹生 光咲, 勢力 薫, 五十嵐 久人, 桑木 崇宏, 田沼 将人, 中澤 敬信, 山口 瞬, 山中 章弘, 橋本 均  

    日本生物学的精神医学会・日本神経精神薬理学会合同年会プログラム・抄録集39回・47回 巻   頁: 173 - 173   2017年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本生物学的精神医学会・日本神経精神薬理学会  

    researchmap

  6. Saturated Excitation Microscopy Using Image Subtraction (光・量子デバイス研究会・International Symposium on Biomedical Optics (バイオメディカルフォトニクス応用))

    Nawa Yasunori, Yonemaru Yasuo, Kasai Atsushi, Smith Nicholas, Hashimoto Hitoshi, Kawata Satoshi, Fujita Katsumasa  

    電気学会研究会資料. OQD = The papers of technical meeting on optical and quantum devices, IEE Japan2017 巻 ( 1 ) 頁: 17 - 20   2017年3月

     詳細を見る

    記述言語:英語   出版者・発行元:電気学会  

    researchmap

  7. Studies on the molecular mechanism of clozapine action with iPSC technology 査読有り

    Fujiwara Mikiya, Kikuchi Masataka, Nagayasu Kazuki, Nakazawa Takanobu, Yamamori Hidenaga, Kasai Atsushi, Hayata-Takano Atsuko, Shintani Norihito, Fujimoto Michiko, Yasuda Yuka, Ishikawa Mitsuru, Akamatsu Wado, Okano Hideyuki, Nakaya Akihiro, Hashimoto Hitoshi, Hashimoto Ryota  

    JOURNAL OF PHARMACOLOGICAL SCIENCES130 巻 ( 3 ) 頁: S254   2016年3月

  8. Whole-brain activity mapping after restraint stress and analysis of neuronal innervation of the activated nucleus 査読有り

    Niu Misaki, Kasai Atsushi, Seiriki Kaoru, Yamaguchi Shun, Yamanaka Akihiro, Nakazawa Takanobu, Hashimoto Hiroshi  

    JOURNAL OF PHARMACOLOGICAL SCIENCES130 巻 ( 3 ) 頁: S164   2016年3月

  9. Myeloid Cell Derived Leucine Rich alpha 2 Glycoprotein Attenuates Adverse Cardiac Remodeling After Myocardial Infarction

    Shohei Kumagai, Hiroyuki Nakayama, Minoru Fujimoto, Hiromi Honda, Satoshi Serada, Atsushi Kasai, Masanori Obana, Yasushi Sakata, Yoshiki Sawa, Tetsuji Naka, Yasushi Fujio  

    CIRCULATION132 巻   2015年11月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:LIPPINCOTT WILLIAMS & WILKINS  

    Web of Science

    researchmap

  10. A new imaging system to detect whole brain structural and functional alterations at cellular and subcellular levels 査読有り

    Seiriki Kaoru, Kasai Atsushi, Niu Misaki, Yamaguchi Shun, Hashimoto Takeshi, Hashimoto Hitoshi  

    JOURNAL OF PHARMACOLOGICAL SCIENCES128 巻 ( 3 ) 頁: S93   2015年7月

  11. PACAPシグナルによる精神神経機能調節におけるセロトニン2A受容体シグナルの関与

    早田敦子, 狭間啓佑, 森口啓太, 吾郷由希夫, 円丁直樹, 中澤敬信, 永安一樹, 笠井淳司, 尾中勇祐, 新谷紀人, 馬場明道, 橋本均  

    日本神経精神薬理学雑誌35 巻   頁: 55 - 56   2015年

     詳細を見る

  12. 「脳の科学Up Date」 最近の全脳三次元解析の現状と展望

    笠井 淳司, 橋本 均  

    脳2117 巻 ( 4 ) 頁: 115 - 119   2014年10月

     詳細を見る

  13. Altered expression of PACAP in the mPFC in depression-like states induced by chronic social defeat stress

    Keisuke Hazama, Atsushi Kasai, Sumiaki Ogawa, Atsuko Hayata, Norihito Shintani, Akemiti Baba, Hitoshi Hashimoto  

    JOURNAL OF PHARMACOLOGICAL SCIENCES124 巻   頁: 187P - 187P   2014年

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:JAPANESE PHARMACOLOGICAL SOC  

    Web of Science

    researchmap

  14. The balance between BMP and TGF-beta signaling at an early stage steers serotonergic differentiation from ES cells

    Atsushi Yamasaki, Atsushi Kasai, Akihiro Toi, Maki Kurita, Atsuko Hayata-Takano, Kazuki Nagayasu, Norihito Shintani, Akemichi Baba, Hitoshi Hashimoto  

    JOURNAL OF PHARMACOLOGICAL SCIENCES124 巻   頁: 181P - 181P   2014年

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:JAPANESE PHARMACOLOGICAL SOC  

    Web of Science

    researchmap

  15. ANALYSIS OF PACAP SIGNALING-MEDIATED RECEPTOR INTERNALIZATION USING THE HALOTAG SYSTEM

    A. Hayata, N. Encho, K. Moriguchi, T. Fujino, N. Shintani, A. Kasai, A. Baba, H. Hashimoto  

    JOURNAL OF MOLECULAR NEUROSCIENCE51 巻   頁: S203 - S203   2013年11月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:HUMANA PRESS INC  

    Web of Science

    researchmap

  16. PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE (PACAP) PLAYS SIGNIFICANT ROLES IN DENDRITIC SPINE FORMATION AND MORPHOLOGY

    S. Higashi, K. Seiriki, A. Hayata, K. Ogata, N. Shintani, A. Kasai, D. Vaudry, A. Baba, H. Hashimoto  

    JOURNAL OF MOLECULAR NEUROSCIENCE51 巻   頁: S226 - S226   2013年11月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:HUMANA PRESS INC  

    Web of Science

    researchmap

  17. 核酸医薬品開発に向けた現状と展望 招待有り

    笠井 淳司  

    脳2116 巻   頁: 89 - 94   2013年

     詳細を見る

    記述言語:日本語   掲載種別:記事・総説・解説・論説等(商業誌、新聞、ウェブメディア)  

    researchmap

  18. Effect of apelin siRNA on the maturation of blood vessels

    Yuki Ishimaru, Nao Matsumoto, Kosuke Higashino, Akihide Sumino, Atsushi Kasai, Yasuhiro Yoshioka, Akiko Yamamuro, Sadaaki Maeda  

    JOURNAL OF PHARMACOLOGICAL SCIENCES118 巻   頁: 160P - 160P   2012年

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:JAPANESE PHARMACOLOGICAL SOC  

    Web of Science

    researchmap

  19. siRNA targeting apelin prevents the increase in capillary density and abnormal vessels in retina induced by hypoxia

    Yuki Ishimaru, Atsushi Kasai, Kosuke Higashino, Yasuhiro Yoshioka, Akiko Yamamuro, Sadaaki Maeda  

    JOURNAL OF PHARMACOLOGICAL SCIENCES118 巻   頁: 96P - 96P   2012年

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:JAPANESE PHARMACOLOGICAL SOC  

    Web of Science

    researchmap

  20. Dopamine attenuates LPS-induced cytokine expression in microglial cells

    Yasuhiro Yoshioka, Yuta Sugino, Kazuya Nishimoto, Takuma Nishizawa, Akiko Yamamuro, Atsushi Kasai, Sadaaki Maeda  

    JOURNAL OF PHARMACOLOGICAL SCIENCES115 巻   頁: 188P - 188P   2011年

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:JAPANESE PHARMACOLOGICAL SOC  

    Web of Science

    researchmap

  21. 眼内血管新生性疾患におけるアペリンの役割 招待有り

    笠井 淳司  

    日本薬理学雑誌131 巻 ( 8 ) 頁: 1201 - 1206   2011年

     詳細を見る

    記述言語:日本語   掲載種別:記事・総説・解説・論説等(学術雑誌)  

    DOI: 10.1248/yakushi.131.1201

    researchmap

  22. Suppression of pathological retinal angiogenesis by siRNA targeting apelin

    Atsushi Kasai, Yuki Ishimaru, Fumi Gomi, Yasuhiro Yoshioka, Akiko Yamamuro, Sadaaki Maeda  

    JOURNAL OF PHARMACOLOGICAL SCIENCES115 巻   頁: 64P - 64P   2011年

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:JAPANESE PHARMACOLOGICAL SOC  

    Web of Science

    researchmap

  23. Proteasome inhibitor induces apoptosis through ROS generation by NOX5

    Akiko Yamamuro, Maya Nakagawa, Kei Hasegawa, Aya Katoh, Yasuhiro Yoshioka, Atsushi Kasai, Sadaaki Maeda  

    JOURNAL OF PHARMACOLOGICAL SCIENCES115 巻   頁: 189P - 189P   2011年

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:JAPANESE PHARMACOLOGICAL SOC  

    Web of Science

    researchmap

  24. Noradrenaline protects astrocytes from H2O2-induced cell death via beta(3)-receptor stimulation

    Yasuhiro Yoshioka, Toshiki Motegi, Rie Tsujimoto, Ami Morishita, Chiharu Shirasu, Akiko Yamamuro, Atsushi Kasai, Sadaaki Maeda  

    JOURNAL OF PHARMACOLOGICAL SCIENCES115 巻   頁: 243P - 243P   2011年

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:JAPANESE PHARMACOLOGICAL SOC  

    Web of Science

    researchmap

  25. Apelin is involved in the progression of amyotrophic lateral sclerosis

    Atsushi Kasai, Toshihiko Kinjo, Yasuhiro Yoshioka, Akiko Yamamuro, Kumiko Ishige, Yoshihisa Ito, Sadaaki Maeda  

    NEUROSCIENCE RESEARCH68 巻   頁: E197 - E198   2010年

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:ELSEVIER IRELAND LTD  

    DOI: 10.1016/j.neures.2010.07.2446

    Web of Science

    researchmap

  26. Apelin promotes endothelial cell growth during hypoxia-induced retinal angiogenesis

    Yuki Ishimaru, Atsushi Kasai, Toshihiko Kinjo, Yasuhiro Yoshioka, Akiko Yamamuro, Norihito Shintani, Akemichi Baba, Sadaaki Maeda  

    JOURNAL OF PHARMACOLOGICAL SCIENCES112 巻   頁: 68P - 68P   2010年

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:JAPANESE PHARMACOLOGICAL SOC  

    Web of Science

    researchmap

  27. Dopamine protects neurons from LPS-induced cell death in co-culture of neurons and microglial cells

    Tadahiro Kitamoto, Yasuhiro Yoshioka, Akiko Yamamuro, Atsushi Kasai, Sadaaki Maeda  

    JOURNAL OF PHARMACOLOGICAL SCIENCES112 巻   頁: 140P - 140P   2010年

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:JAPANESE PHARMACOLOGICAL SOC  

    Web of Science

    researchmap

  28. 生理活性ペプチド: Apelin

    笠井 淳司  

      13 巻   頁: 89 - 93   2010年

     詳細を見る

    記述言語:日本語   掲載種別:記事・総説・解説・論説等(商業誌、新聞、ウェブメディア)  

    researchmap

  29. マウス表現型の網羅的解析法

    笠井 淳司  

    実践行動薬理学   頁: 20 - 26   2010年

     詳細を見る

    記述言語:日本語   掲載種別:記事・総説・解説・論説等(その他)  

    researchmap

  30. Noradrenaline protects neurons from hydrogen peroxide-induced cell death by increasing the release of glutathione from astrocytes

    Toshiki Motegi, Yasuhiro Yoshioka, Akiko Yamamuro, Atsushi Kasai, Sadaaki Maeda  

    JOURNAL OF PHARMACOLOGICAL SCIENCES112 巻   頁: 141P - 141P   2010年

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:JAPANESE PHARMACOLOGICAL SOC  

    Web of Science

    researchmap

  31. Noradrenaline protects neurons from H2O2-induced cell death by increasing the release of glutathione from astrocytes via beta-adrenoreceptor stimulation

    Yasuhiro Yoshioka, Toshiki Motegi, Akiko Yamamuro, Atsushi Kasai, Sadaaki Maeda  

    NEUROSCIENCE RESEARCH68 巻   頁: E347 - E347   2010年

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:ELSEVIER IRELAND LTD  

    DOI: 10.1016/j.neures.2010.07.1538

    Web of Science

    researchmap

  32. Apelin is required for the development of oxygen-induced retinopathy

    Atsushi Kasai, Toshihiko Kinjo, Yasuhiro Yoshioka, Akiko Yamamuro, Norihito Shintani, Hitoshi Hashimoto, Akemichi Baba, Sadaaki Maeda  

    JOURNAL OF PHARMACOLOGICAL SCIENCES109 巻   頁: 201P - 201P   2009年

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:JAPANESE PHARMACOLOGICAL SOC  

    Web of Science

    researchmap

  33. Dopamine inhibits NO production by LPS-activated microglia through the formation of quinoprotein

    Yasuhiro Yoshioka, Azusa Tozawa, Tadahiro Kitamoto, Akiko Yamamuro, Atsushi Kasai, Sadaaki Maeda  

    JOURNAL OF PHARMACOLOGICAL SCIENCES109 巻   頁: 128P - 128P   2009年

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:JAPANESE PHARMACOLOGICAL SOC  

    Web of Science

    researchmap

  34. Noradrenaline attenuates hydrogen peroxide-induced cell death of astrocyte through the increase in the level of intracellular glutathione

    Hisatsugu Kadoi, Yasuhiro Yoshioka, Akiko Yamamuro, Atsushi Kasai, Sadaaki Maeda  

    JOURNAL OF PHARMACOLOGICAL SCIENCES109 巻   頁: 129P - 129P   2009年

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:JAPANESE PHARMACOLOGICAL SOC  

    Web of Science

    researchmap

  35. Dysfunction of ubiquitin-proteasome syetem induces neuronal cell death through an activation of NADPH oxidase

    Akiko Yamamuro, Takumi Iyama, Yasuhiro Yoshioka, Atsushi Kasai, Sadaaki Maeda  

    JOURNAL OF PHARMACOLOGICAL SCIENCES109 巻   頁: 153P - 153P   2009年

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:JAPANESE PHARMACOLOGICAL SOC  

    Web of Science

    researchmap

  36. 虚血性疾患治療を目指した最新トランスレーショナルリサーチ (生体機能と創薬シンポジウム2008--生命システムにおける情報ネットワークの重要性を解く 講演要旨集) -- (シンポジウム 慢性・難治性疾患治療を目指した最新のトランスレーショナルリサーチ)

    笠井淳司, 新谷紀人, 加藤秀昭  

    薬学雑誌128 巻   頁: 45 - 48   2008年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本薬学会  

    researchmap

  37. Caspase-9 is a substrate of caspase-4

    Akiko Yamamuro, Yu Ohshima, Yasuhiro Yoshioka, Atsushi Kasai, Sadaaki Maeda  

    JOURNAL OF PHARMACOLOGICAL SCIENCES106 巻   頁: 234P - 234P   2008年

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:JAPANESE PHARMACOLOGICAL SOC  

    Web of Science

    researchmap

  38. Proteasome inhibitor induces cell death via production of reactive oxygen species in human neuroblastoma SH-SY5Y cells

    Yu Ohshima, Akiko Yamamuro, Yasuhiro Yoshioka, Atsushi Kasai, Sadaaki Maeda  

    JOURNAL OF PHARMACOLOGICAL SCIENCES106 巻   頁: 232P - 232P   2008年

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:JAPANESE PHARMACOLOGICAL SOC  

    Web of Science

    researchmap

  39. Noradrenaline and adrenaline attenuate hydrogen peroxide-induced cell death in astrocyte

    Hisatsugu Kadoi, Yasuhiro Yoshioka, Akiko Yarnamuro, Atsushi Kasai, Sadaaki Maeda  

    JOURNAL OF PHARMACOLOGICAL SCIENCES106 巻   頁: 185P - 185P   2008年

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:JAPANESE PHARMACOLOGICAL SOC  

    Web of Science

    researchmap

  40. Negative feedback regulation of NO production in LPS-stimulated microglia

    Nobuo Takeda, Yasuhiro Yoshioka, Akiko Yarriamuro, Atsushi Kasai, Sadaaki Maeda  

    JOURNAL OF PHARMACOLOGICAL SCIENCES106 巻   頁: 128P - 128P   2008年

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:JAPANESE PHARMACOLOGICAL SOC  

    Web of Science

    researchmap

  41. Dopamine inhibits NO production by LPS-activated microglia

    Azusa Tozawa, Yasuhiro Yoshioka, Akiko Yamamuro, Atsushi Kasai, Sadaaki Maeda  

    JOURNAL OF PHARMACOLOGICAL SCIENCES106 巻   頁: 128P - 128P   2008年

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:JAPANESE PHARMACOLOGICAL SOC  

    Web of Science

    researchmap

  42. Lack of apelin results in retardation of retinal vascular development

    Atsushi Kasai, Norihito Shintani, Hideaki Kato, Satoshi Matsuda, Fumi Gomi, Hitoshi Hashimoto, Michiya Kakuda, Yasuo Tano, Akemichi Baba  

    JOURNAL OF PHARMACOLOGICAL SCIENCES103 巻   頁: 63P - 63P   2007年

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:JAPANESE PHARMACOLOGICAL SOC  

    Web of Science

    researchmap

▼全件表示

講演・口頭発表等 9

  1. サポートベクターマシーンを用いたストレス応答制御機構の解明

    笠井淳司

    第2回脳科学サロン「脳とAI」  2020年10月10日 

     詳細を見る

    開催年月日: 2020年10月

    記述言語:日本語  

    researchmap

  2. 脳機能解明に向けた全脳多色蛍光標識法の開発 招待有り

    笠井淳司

    第67回日本実験動物学会総会  2020年5月24日 

     詳細を見る

    開催年月日: 2020年5月

    記述言語:日本語   会議種別:公開講演,セミナー,チュートリアル,講習,講義等  

    researchmap

  3. 筋萎縮性側索硬化症の病態進行におけるアペリンの役割

    笠井 淳司

    Neuro2010  2010年9月 

     詳細を見る

    記述言語:日本語   会議種別:ポスター発表  

    researchmap

  4. レーザー誘発脈絡膜血管新生におけるapelin-APJ systemの役割

    笠井 淳司

    次世代を担う創薬・医療薬理シンポジウム2012  2012年9月1日 

     詳細を見る

    記述言語:日本語   会議種別:シンポジウム・ワークショップ パネル(公募)  

    researchmap

  5. PACAP欠損マウスにおける慢性的な社会的敗北ストレス誘発うつ様症状の消失

    笠井 淳司

    日本薬学会第133年会  2013年3月 

     詳細を見る

    記述言語:日本語   会議種別:ポスター発表  

    researchmap

  6. Inhibition of the apelin-APJ signal switches endothelial cells from proliferative to mature state in pathological retinal angiogenesis

    笠井 淳司

    第21回日本血管生物医学会総会学術集会  2013年9月 

     詳細を見る

    記述言語:日本語   会議種別:口頭発表(一般)  

    researchmap

  7. Hypoxia induced apelin mRNA expression in astrocytes 国際会議

    笠井 淳司

    CPT2008  2008年7月29日 

     詳細を見る

    記述言語:英語   会議種別:ポスター発表  

    researchmap

  8. Apelin is a crucial factor for hypoxia-induced retinal angiogenesis 国際会議

    笠井 淳司

    WorldPharma2010  2010年7月 

     詳細を見る

    記述言語:英語   会議種別:ポスター発表  

    researchmap

  9. Apelin is a crucial factor for hypoxia-induced retinal angiogenesis 国際会議

    笠井 淳司

    第18回日本血管生物医学会学術集会/8th Korea-Japan Joint Symposium on Vascular Biology  2010年12月 

     詳細を見る

    記述言語:日本語   会議種別:口頭発表(一般)  

    researchmap

▼全件表示

科研費 30

  1. 嫉妬の理解と創出:生物ロボティクス融合による共生社会のための社会情動の理解

    研究課題/研究課題番号:22B306  2022年5月 - 2025年3月

    日本学術振興会  科学研究費助成事業 学術変革領域研究(B)  学術変革領域研究(B)

    笠井 淳司

      詳細を見る

    担当区分:研究代表者 

    researchmap

  2. 胎児医療に向けた神経発達障害発症機構の解明

    2021年4月 - 2024年3月

    国立研究開発法人科学技術振興機構  創発的研究支援事業  創発的研究支援事業

    笠井淳司

      詳細を見る

    担当区分:研究代表者 

    researchmap

  3. 全脳細胞解析による不安制御に関わる神経基盤の解明と創薬研究への応用

    研究課題/研究課題番号:20H03391  2020年4月 - 2023年3月

    日本学術振興会  科学研究費助成事業 基盤研究(B)  基盤研究(B)

    笠井 淳司

      詳細を見る

    担当区分:研究代表者 

    配分額:17680000円 ( 直接経費:13600000円 、 間接経費:4080000円 )

    近年、不安障害の患者数は急増しており、認知症患者数よりも多く、社会負担が甚大なが
    ら、成因・病態機構や治療機序が未解明で新規治療薬の開発も長年失敗している。本研究では、それを打開するため、応募者らが最近開発した方法論を駆使し、従来研究では見逃されていた病態の詳細な分子・神経基盤の解明を通じ、新たな治療法の確立に貢献する。具体的には、最新の高精細全脳イメージング法および単一細胞トランスクリプトーム解析法を組み合わせ、強い精神的ストレスに暴露された脳を、全脳細胞レベルで解析し、ストレス誘発不安様行動を制御する神経基盤を明らかにする。
    近年、不安障害の患者数は急増しており、認知症患者数よりも多く、社会負担が甚大ながら、成因・病態機構や治療機序が未解明で新規治療薬の開発も長年失敗している。本研究では、それを打開するため、応募者らが最近開発した方法論を駆使し、従来研究では見逃されていた病態の詳細な分子・神経基盤の解明を通じ、新たな治療法の確立に貢献する。具体的には、最新の高精細全脳イメージング法および単一細胞トランスクリプトーム解析法を組み合わせ、強い精神的ストレスに暴露された脳を、全脳細胞レベルで解析し、ストレス誘発不安様行動を制御する神経基盤を明らかにすることを目指している。本年度は、mRNAの発現を二重蛍光標識in situ hybridization法により明らかにし、ストレス応答性神経細胞のマーカー分子を同定した。また、同定したマーカー分子の発現細胞特異的にCreリコンビナーゼを発現するマウスを作成し、アデノ随伴ウイルスベクターを用いて、特異性を確認した。
    今後は、ストレス応答発現細胞の神経活動を計測し、その挙動から不安関連行動との関係性を詳細に明らかにすることを目指す。
    計画通り進捗し、ストレス応答候補分子のCreリコンビナーゼ特異的なマウスの作出に成功したため。
    神経細胞種特異的な活動操作や活動計測を行い、不安関連行動との関係性をより詳細に明らかにする。

    researchmap

  4. ストレスによる情動障害に関わる神経基盤の解明と創薬研究への応用

    研究課題/研究課題番号:17H05054  2017年4月 - 2020年3月

    日本学術振興会  科学研究費助成事業 若手研究(A)  若手研究(A)

    笠井 淳司

      詳細を見る

    担当区分:研究代表者 

    配分額:24700000円 ( 直接経費:19000000円 、 間接経費:5700000円 )

    精神的なストレスは、うつ病などのストレス性精神疾患の発症の原因になりうるものの、その発症や快復の機序は不明である。そこで申請者は、ストレス応答の制御と破綻に関わる神経基盤を明らかにし、精神疾患の新たな創薬戦略の提唱を目指している。これまでに、独自に開発した全脳細胞計測システムFASTを用いて、ストレス応答に重要な脳領域を見出した。当該領域のストレス応答における役割を明らかにするため、本年度は、その神経活動操作を実施し、情動に関連する脳領域の活性化と不安様行動などを誘発することを明らかにした。

    researchmap

  5. ストレスによる睡眠障害の発症機序解明と治療標的分子の探索

    研究課題/研究課題番号:23K27331  2024年2月 - 2026年3月

    科学研究費助成事業  基盤研究(B)

    笠井 淳司

      詳細を見る

    担当区分:研究代表者 

    配分額:11310000円 ( 直接経費:8700000円 、 間接経費:2610000円 )

  6. ストレスによる睡眠障害の発症機序解明と治療標的分子の探索

    研究課題/研究課題番号:23H02640  2023年4月 - 2026年3月

    科学研究費助成事業  基盤研究(B)

    笠井 淳司, 林 悠

      詳細を見る

    担当区分:研究代表者 

    配分額:18850000円 ( 直接経費:14500000円 、 間接経費:4350000円 )

    日本人の約20%が睡眠障害を抱えており、その半数がストレスに起因するとされている。しかし、不眠症の発症メカニズムは未だ不明であり、結果として睡眠/覚醒サイクルを強制的にコントロールしているのが現状である。本研究では、現状を打開するため、応募者らが最近得た知見を基に、独自の方法論を駆使して睡眠障害の詳細な分子・神経基盤を解明し、新たな治療法の確立に貢献する。

  7. レジリエンスを獲得させる新たなストレス関連障害治療戦略

    研究課題/研究課題番号:22K19378  2022年6月 - 2024年3月

    日本学術振興会  科学研究費助成事業 挑戦的研究(萌芽)  挑戦的研究(萌芽)

    笠井 淳司

      詳細を見る

    担当区分:研究代表者 

    配分額:6500000円 ( 直接経費:5000000円 、 間接経費:1500000円 )

    高精細な高速全脳イメージングシステムFASTと、脳内空間情報を保持したシングル細胞トランスクリプトーム解析法を組み合わせ、ストレスレジリエンスを高める神経細胞のシングル細胞発現解析、薬理学的介入による神経活動への影響評価、行動薬理学的な検証を行う。
    ストレスは、ヒトの心身に悪影響を及ぼし、様々な精神疾患の原因になると考えられている。近年世界中で精神疾患患者数が増加しており、特に、気分障害やストレス関連障害の患者数の増加率は高い。最近ではCOVID-19感染の回復後に、約3割の患者が心的外傷後ストレス障害を発症するとの報告もある。また患者の約3割が治療抵抗性を示すことや寛解期からの再発リスクが高いことなど、既存のストレス関連障害の治療満足度は低い。既存の精神療法と薬物療法の治療法では、症状が改善した寛解期に患者自身でストレス要因に対処する力をつける必要がある。従って、患者自身の個々の力や環境に依存せず、ストレスレジリエンス(回復力)を高めれば、治療抵抗性や再発リスクを軽減できることに繋がり、有益な新規治療戦略になると考えられる。しかしながら、このストレスレジリエンスの生物学的なメカニズムは未だほとんど明らかにされていない。そこで本課題では、ストレスレジリエンスを高める神経細胞の遺伝的特性を同定し、その特性に基づき薬理学的に介入し、レリエンスを高める新規のストレス関連障害治療戦略を動物実験で実証することを目指している。本年度は、社会的敗北ストレス応答性神経細胞のシングル細胞発現解析、薬理学的介入による神経活動への影響評価を実施した。
    計画通り進捗し、シングル細胞トランスクリプトーム解析を終了し、薬理学的介入試験を開始できたため。
    行動薬理学的な介入の例数を重ね、レジリエンス獲得に向けた評価を試みる。

    researchmap

  8. げっ歯類の嫉妬:全脳活動計測による嫉妬の生成モジュールの探索

    研究課題/研究課題番号:22H05080  2022年5月 - 2025年3月

    日本学術振興会  科学研究費助成事業 学術変革領域研究(B)  学術変革領域研究(B)

    笠井 淳司, 野村 洋, 野村 洋

      詳細を見る

    担当区分:研究代表者 

    配分額:56290000円 ( 直接経費:43300000円 、 間接経費:12990000円 )

    社会的情動の一つである嫉妬(不公平嫌悪)は、時空間的に動的な脳活動によって処理さ
    れるため、静的な神経回路地図を描いてきた従来の研究戦略からの変革が必要である。そこで独自の技術を組み合わせ嫉妬に関わるミクロ・マクロ制御のダイナミックな活動連関を明らかにする。さらに大規模な活動計測・詳細な活動操作・嫉妬表出の観察を通して、社会的情動モデルの機能モジュールの仮説を実証し、本領域で作成するヒト共生ロボットの開発に貢献し、共生社会への応用を目指す。

    researchmap

  9. 嫉妬の科学推進のための戦略的研究推進支援

    研究課題/研究課題番号:22H05079  2022年5月 - 2025年3月

    日本学術振興会  科学研究費助成事業 学術変革領域研究(B)  学術変革領域研究(B)

    笠井 淳司, 田中 宏和, 野村 洋, 揚妻 正和, 日永田 智絵, 則武 厚, 田中 宏和, 野村 洋, 揚妻 正和, 日永田 智絵, 則武 厚

      詳細を見る

    担当区分:研究代表者 

    配分額:5070000円 ( 直接経費:3900000円 、 間接経費:1170000円 )

    本総括班では、「嫉妬」を神経科学とロボティクスの手法を融合して解明するため、各計画班の緊密な領域内連携を促し、各計画班の研究支援を実施する。また、積極的に研究成果の発信、領域外研究者への技術共有や国際共同研究の基盤構築を実施し、嫉妬の科学を周知することを目指している。本年度は、キックオフミーティング、数理解析サマーセミナー、ロボティクス研究セミナーを開催し、領域内・外の研究者の理解度向上とともに交流を促した。また、第100回日本生理学会大会にて、共催シンポジウムを開催し、本領域の成果を発信し、関係学会の会員に周知を図った。また、ホームページを開設し、本領域についての成果や研究方針等の情報を発信する基盤を構築した。

    researchmap

  10. 多階層的解析を基盤とした薬物依存症の解明

    2021年7月 - 2025年3月

    国立研究開発法人日本医療研究開発機構  脳とこころの研究推進プログラム(精神・神経疾患メカニズム解明プロジェクト) 

    永井拓, 船橋靖広, 笠井淳司, 吉本潤一郎

      詳細を見る

    担当区分:研究分担者 

    researchmap

  11. グリアエングラムの同定と回路機能的意義の解明

    研究課題/研究課題番号:21H02588  2021年4月 - 2024年3月

    日本学術振興会  科学研究費助成事業 基盤研究(B)  基盤研究(B)

    長井 淳, 笠井 淳司, 笠井 淳司

      詳細を見る

    担当区分:研究分担者 

    アストロサイトは哺乳類の中枢神経系にタイル状に存在するグリア細胞の一種であり、神経回路活動の入出力を制御する細胞として考えられている。しかし、行動中の動物におけるその活動パターン・分布や詳細な機能については未解明な点が多く残されている。本研究課題は,特定の記憶が形成された動物でのみ活性化するアストロサイト活動を補足し、操作することによって、グリアエングラムの存在とその意義を解明することを目的としている。
    この目的を達成するために、マウスやウイルスベクターを用いた遺伝学やアストロサイト特異的摂動法を基軸に、全脳イメージングや条件付け記憶アッセイを組み合わせた実験系を用いている。これにより、アストロサイト活動依存的に様々な外来遺伝子(蛍光蛋白質や光・薬理遺伝学プローブなど)を行動パラダイム特異的に発現誘導することができ、アストロサイトの詳細な形態とカルシウム動態の可視化、さらには光遺伝学・薬理遺伝学を駆使しての活動興奮・抑制の誘導などの遺伝学的神経活動操作を行うことが、世界で初めて可能となる。
    初年度は、(1)PHP.eBカプシドAAVにパッケージングした全脳レベルのウイルス感染の確立、(2)アストロサイト特異的ベクターによる85-97%のアストロサイト特異性およびペネトレーションの確認、(3)DREADDによるアストロサイト活動依存的な外来遺伝子発現誘導の確認を行なった。さらに、大阪大学の笠井淳司博士らと共同で,アストロサイトの全脳イメージング、3D撮像、インフォマティクスのプラットフォームを構築に着手した。これらの知見は次年度に行う特定の記憶形成に相関するアストロサイト活動の全脳マッピングおよび薬理遺伝学的操作実験の重要な基盤となる。

    researchmap

  12. マルチスケール解析によるストレス性精神疾患の構成的理解

    研究課題/研究課題番号:21H00200  2021年4月 - 2023年3月

    日本学術振興会  科学研究費助成事業 新学術領域研究(研究領域提案型)  新学術領域研究(研究領域提案型)

    笠井 淳司

      詳細を見る

    担当区分:研究代表者 

    配分額:6110000円 ( 直接経費:4700000円 、 間接経費:1410000円 )

    本課題では、分子、個々の神経活動、領野レベルの神経活動、行動レベルの多階層の統合的な解析を通じて、脳内のストレス応答性神経細胞が、どのようにして不安様行動やうつ様行動の発現制御に関わるのかを詳細に明らかにすることを目指している。本年度は、シングル細胞RNA-seq解析により、ストレス応答性神経細胞の分子特性を明らかにし、マーカー分子となる遺伝子の脳内局在をin situ hybridization法により確認した。さらに、そのマーカー分子発現細胞特異的にCreリコンビナーゼを発現するマウスの作製に着手した。

    researchmap

  13. 多階層オミックス解析による発達障害の発症機序の解明

    研究課題/研究課題番号:20K21479  2020年7月 - 2022年3月

    日本学術振興会  科学研究費助成事業 挑戦的研究(萌芽)  挑戦的研究(萌芽)

    笠井 淳司

      詳細を見る

    担当区分:研究代表者 

    配分額:6500000円 ( 直接経費:5000000円 、 間接経費:1500000円 )

    本課題では、発達障害発症のメカニズムを明らかにし先制医療・新規治療法の確立に貢献する画期的シーズを創出するため、胎生期の神経細胞の全脳レベルの移動・空間配置の定量的な評価法を確立し、発達障害モデル動物の細胞の分化・分布の脳内変化を明らかにする。さらに、最も影響される細胞群から遺伝子発現解析を実施し、脳内変化の新たなメカニズムを提唱する。そのメカニズムに基づいて薬理学的に介入し、因果関係を明らかにすることを目指している。本年度は、胎生期の興奮性神経細胞および抑制性神経細胞をそれぞれ誕生日によって遺伝学的に標識する方法を導入した。今後は、特定の時期の環境要因によるエピジェネティックスの変化が胎生期の神経細胞の移動等に与える影響を評価し、脳内の構造・機能変化の重要な部位を特定し、その特性評価等を実施する予定である。

    researchmap

  14. 脳疾患の解明と創薬へ向けた疾患モデル脳のマルチスケールデータ解析

    研究課題/研究課題番号:20H00492  2020年4月 - 2023年3月

    日本学術振興会  科学研究費助成事業 基盤研究(A)  基盤研究(A)

    橋本 均, 笠井 淳司, 勢力 薫, 笠井 淳司, 勢力 薫

      詳細を見る

    担当区分:研究分担者 

    本研究は、脳疾患と脳神経機能の発現機構の解析に貢献する観察・操作技術横断的な研究を推進するため、広範な空間分解能イメージングと細胞標識レポーターを用いた高精細・脳領域・細胞アトラスの構築を行い、正常脳と病態脳をアンバイアスに比較解析する方法を構築することを目的にしている。
    本年度は、高精細全脳イメージング装置FASTを改良し、シナプス構造である樹状突起スパイン等を観察するための超解像ユニットを導入すると共に、z方向の位置精度の向上、さらに高・低倍の対物レンズの併用・自動切り替え装置の開発を行った。
    また、多機能アトラスに統合するデータとして、保有する3q29欠失マウスや薬物投与マウスの全脳活動マップのデータを取得した。

    researchmap

  15. 負の情動行動を制御する脳領域間情報動態の解明

    研究課題/研究課題番号:20H05065  2020年4月 - 2022年3月

    日本学術振興会  科学研究費助成事業 新学術領域研究(研究領域提案型)  新学術領域研究(研究領域提案型)

    笠井 淳司

      詳細を見る

    担当区分:研究代表者 

    配分額:5720000円 ( 直接経費:4400000円 、 間接経費:1320000円 )

    負の情動行動制御におけるストレス情報のベクトルの向きや重みなど多領野の活動連関の制御機構を明らかにする。さらに、複数脳領域の活動パターンによる脳機能制御など脳特有の性質(Emergent properties)の理解を目指す。
    精神的ストレスは、ストレス応答機構としての不快情動を惹起し、不安などの情動行動を引き起こす。情動行動は、複数の脳情報の並列処理や同期的活動など、複数の脳領域の活動連関により制御されると考えられる。しかしながら、その詳細は不明である。そこで本課題では、多領野の活動を制御する脳領域のカルシウムイメージングを行った。観察した約20%の細胞の神経活動だけが、不安関連行動の直後に上昇することを見出した。この結果は、不安関連行動の制御に新たな細胞集団が関与する可能性を示しており、探索行動、覚醒レベル、情報処理などの不安応答プロセスにおいて、新たな神経メカニズムの一端を明らかにすることに成功した。
    令和3年度が最終年度であるため、記入しない。
    令和3年度が最終年度であるため、記入しない。

    researchmap

  16. 中枢疾患創薬を加速する全脳細胞解析による不安障害の標的分子の探索

    2020年4月 - 2022年3月

    蓬庵社  令和2年度(第25回)特別研究助成 

    笠井淳司

      詳細を見る

    担当区分:研究代表者 

    researchmap

  17. 母体免疫活性と胎仔脳の相互作用に起因する社会性行動の異常に関わる全脳活動変化と分子基盤の解明

    2019年6月 - 2021年3月

    旭硝子財団  2019年度研究助成金 

    笠井 淳司

      詳細を見る

    担当区分:研究代表者  資金種別:競争的資金

    researchmap

  18. トランスオミックス解析によるストレス性精神疾患の構成的理解

    研究課題/研究課題番号:19H05217  2019年4月 - 2021年3月

    日本学術振興会  科学研究費助成事業 新学術領域研究(研究領域提案型)  新学術領域研究(研究領域提案型)

    笠井 淳司

      詳細を見る

    担当区分:研究代表者 

    配分額:6110000円 ( 直接経費:4700000円 、 間接経費:1410000円 )

    本課題では、強い精神的ストレスにより惹起される不安様行動に関わる神経基盤の構成的要素を明らかにする。具体的には、全脳神経活動、神経回路網、遺伝子発現のトランスオミックス解析により、ストレス応答に特に重要な神経細胞の特性を、明らかにする。その特性を用いて各階層を操作し、自由行動下神経活動、行動(行動薬理学)の変化を解析し、ストレス性精神疾患の病態を創出する最小パーツを理解する。
    本課題は、精神的ストレスを暴露された脳内の多階層オミックス解析を実施し、ストレス性精神疾患病態の構成的な理解を目指している。昨年度までに、ストレス応答性前障神経細胞のシングル細胞トランスクリプトーム解析を実施し、複数の細胞群に分類した。これらの細胞群の役割を明らかにするため、各細胞の回路情報を全脳イメージングにより明らかにした。特にストレスや恐怖に応答することが知られている扁桃体基底外側核からの入力があることを見出した。また、扁桃体から前障に投射する神経終末を活性化させることにより不安様行動が惹起されることを見出し、ストレス誘発不安様行動に重要な神経回路であることを示した。さらに、前障ストレス応答性神経細胞の分子特性として、高発現する4つの遺伝子を同定することに成功した。今後は、これらの分子の発現制御がストレス性精神疾患の発症に関与するのかについて詳細に解析することにより、ストレス性精神疾患の病態を創出する最小パーツの理解に貢献したい。
    令和2年度が最終年度であるため、記入しない。
    令和2年度が最終年度であるため、記入しない。

    researchmap

  19. 時空間的な細胞特性に基づく精神疾患の新規治療標的分子の探索

    研究課題/研究課題番号:18K19399  2018年6月 - 2020年3月

    日本学術振興会  科学研究費助成事業 挑戦的研究(萌芽)  挑戦的研究(萌芽)

    笠井 淳司, 奥野 浩行, 奥野 浩行

      詳細を見る

    担当区分:研究代表者 

    配分額:6240000円 ( 直接経費:4800000円 、 間接経費:1440000円 )

    創薬標的分子の探索研究において、「脳全体の中から精神疾患の発症に特に重要な個々の細胞の分子レベルの特性」を見出すことが必要である。そこで、本研究では、「脳機能の破綻に最も重要な細胞群を同定し、その時空間的な分子レベルの細胞特性を計測する斬新な方法論を確立」し、さらに「従来細胞集団の平均値でしか記述出来ていない分子レベルの特性を打破し、ストレス耐性を獲得させる新たな概念や機序の創薬標的分子の提唱を目指すことを目的としている。
    本年度は、下記の成果を得た。
    1)In vivo単一細胞の分取法の確立:脳組織内の蛍光標識した単一細胞を分取する方法を確立した。特に、分取過程の刺激による偽陽性を防ぐため、神経活動の活性化を抑制する工夫をし、Arc-dVenusマウス脳から細胞分取までの時間を極力短くする方法を確立した。
    2)特定の脳神経細胞を蛍光標識するAAVベクターを作成し、静脈内投与により脳の細胞を標識する方法を確立した。

    researchmap

  20. 高精細全脳イメージングを用いた負の情動行動制御における多領野連関解析

    研究課題/研究課題番号:18H05132  2018年4月 - 2020年3月

    日本学術振興会  科学研究費助成事業 新学術領域研究(研究領域提案型)  新学術領域研究(研究領域提案型)

    笠井 淳司

      詳細を見る

    担当区分:研究代表者 

    配分額:5720000円 ( 直接経費:4400000円 、 間接経費:1320000円 )

    本研究は、前障のストレス応答神経細胞の活動を回路特異的に操作し、最新光学イメージング法FASTによる全脳活動マッピングを実施し、負の情動行動制御機構における多領野連関の解読を目指している。本年度は、以下の成果を得た。
    1)前障のストレス応答性神経細胞の活動操作による行動変化
    ストレスにより活性化する前障の神経細胞を特異的に活動操作するため、2種類のアデノ随伴ウイルスベクター(AAV)を用いて、ストレス刺激特異的に応答する神経細胞にDREADD受容体を発現させ、活動操作した。その結果、オープンフィールド試験および高架式十字迷路試験において不安様行動を誘発することを見出した。
    2)多領野神経活動に与える影響
    1)と同様にストレスに応答した細胞のみを再度活性化させた際に前頭前皮質や扁桃体を含む多領野の神経活動が活性化する結果を得た。

    researchmap

  21. 脳機能解明に資する細胞種特異的な多色蛍光標識マウスの開発

    2018年

    株式会社ケー・エー・シー  創立40周年記念研究助成 

    笠井 淳司

      詳細を見る

    担当区分:研究代表者  資金種別:競争的資金

    配分額:1000000円 ( 直接経費:1000000円 )

    researchmap

  22. 精神疾患に関わるストレス脆弱性を左右する神経回路基盤の解明

    研究課題/研究課題番号:15K14964  2015年4月 - 2017年3月

    日本学術振興会  科学研究費助成事業 挑戦的萌芽研究  挑戦的萌芽研究

    笠井 淳司, 橋本 均, 山中 章弘, 山口 瞬, 橋本 岳, 橋本 均, 山中 章弘, 山口 瞬, 橋本 岳

      詳細を見る

    担当区分:研究代表者 

    配分額:3770000円 ( 直接経費:2900000円 、 間接経費:870000円 )

    (2)精神的ストレスは、脳の器質的および機能的変化を引き起こすことが知られているが、その詳細な変化は不明であった。本研究では、全脳細胞をサブミクロンの高精細でイメージングする装置を開発し、ストレスによる脳内変化を、先入観なしに探索した。その結果、これまでストレスとの関連が未報告であった微小脳領域がストレス性情動行動に関与することを見出した。

    researchmap

  23. 神経細胞の機能制御におけるミトコンドリア融合阻害の意義

    研究課題/研究課題番号:25670038  2013年4月 - 2016年3月

    日本学術振興会  科学研究費助成事業 挑戦的萌芽研究  挑戦的萌芽研究

    新谷 紀人, 笠井 淳司, 馬場 明道, 笠井 淳司, 馬場 明道

      詳細を見る

    担当区分:研究分担者 

    近年、神経変性疾患の新たな創薬標的として、ミトコンドリアの融合・分裂に注目が集まっている。本研究では、ミトコンドリアの融合を阻害する新規因子:mitochondrial fusion inhibitor(MIFI)の神経細胞の発達/細胞死制御における機能解析を実施した。本研究の結果、MIFIが神経発達の初期過程から機能する可能性や、酸化ストレスと深い関連を示すこと、また神経芽細胞腫SH-SY5Yの障害に対して促進的に働くことが示された。さらに、MIFI発現調節化合物やMIFIの遺伝子欠損マウスなど、MIFIの機能解明に必須となる研究ツールの開発が達成された。

    researchmap

  24. 神経幹細胞の運命を制御する分子基盤の解明

    研究課題/研究課題番号:25670037  2013年4月 - 2015年3月

    日本学術振興会  科学研究費助成事業 挑戦的萌芽研究  挑戦的萌芽研究

    笠井 淳司

      詳細を見る

    担当区分:研究代表者 

    配分額:3900000円 ( 直接経費:3000000円 、 間接経費:900000円 )

    (2)神経幹細胞は、様々な神経系細胞に分化する多能性を有する。本研究では、様々な神経分化誘導法を用いて、神経幹細胞分化前のnoggin処置が、miR-290クラスターの低下等、miRNAの発現パターンを変化させ、セロトニン神経細胞へ分化する割合が上昇することを明らかにした。本結果は、神経幹細胞の多能性には、既に分化指向性がある可能性を示す知見である。

    researchmap

  25. 眼内新生血管発生・成熟・消退メカニズムの解明-アペリンその他の分子の関与

    研究課題/研究課題番号:22591942  2010年 - 2012年

    日本学術振興会  科学研究費助成事業 基盤研究(C)  基盤研究(C)

    五味 文, 大島 佑介, 鈴木 三保子, 生野 恭司, 沢 美喜, 馬場 明道, 笠井 淳司, 大島 佑介, 鈴木 三保子, 生野 恭司, 沢 美喜, 馬場 明道, 笠井 淳司

      詳細を見る

    担当区分:連携研究者  資金種別:競争的資金

    アペリンは網膜血管新生過程に、 VEGF とは独立して関与している。脈絡膜血管新生過程においても、アペリンの関与が明らかとなり、アペリンを標的とした治療法の確立が、現在の抗 VEGF 療法の限界を補える可能性がある。

    researchmap

  26. 遺伝子改変動物を用いた筋萎縮性側索硬化症の発症と病態進行に関する研究

    研究課題/研究課題番号:21590110  2009年 - 2011年

    日本学術振興会  科学研究費助成事業 基盤研究(C)  基盤研究(C)

    前田 定秋, 吉岡 靖啓, 山室 晶子, 石丸 侑希, 笠井 淳司, 吉岡 靖啓, 山室 晶子, 石丸 侑希, 笠井 淳司

      詳細を見る

    担当区分:連携研究者  資金種別:競争的資金

    遺伝性ALSのモデルマウスであるSOD1(G93A)マウスとアペリン欠損マウスから、ダブルミュータントマウスを作製し、ALSの病態進行について解析した。その結果、アペリンがALSの運動神経細胞死に対し保護作用を有すること、その保護作用には、血管内皮増殖因子(VEGF)との強調的な作用が重要であることを明らかにし、アペリンがALSの有用な創薬標的分子となりうることを示した。

    researchmap

  27. 虚血性網膜疾患における新規創薬標的分子としてのapelinの可能性

    研究課題/研究課題番号:21790098  2009年 - 2010年

    日本学術振興会  科学研究費助成事業 若手研究(B)  若手研究(B)

    笠井 淳司

      詳細を見る

    担当区分:研究代表者  資金種別:競争的資金

    配分額:4160000円 ( 直接経費:3200000円 、 間接経費:960000円 )

    糖尿病網膜症などの虚血性網膜疾患では,病態進行に病的血管新生が深く関与している。これまで,研究代表者らは,虚血性網膜症のマウスモデルにおいて,内因性アペリンが網膜血管新生の促進因子であることを明らかにしてきた。今回,apelinが新たな治療標的となるか否かについて検討した。その結果,apelin siRNAの硝子体内投与により網膜apelin発現を約50%抑制し,網膜血管新生および異常血管の形成を有意に抑制することを明らかにした。

    researchmap

  28. オーファンGPCRリガンドapelinの神経保護作用に関する神経薬理学的研究

    2009年

    日本科学協会  笹川科学研究助成 

      詳細を見る

    資金種別:競争的資金

    researchmap

  29. 筋萎縮性側索硬化症モデルマウスを用いた新規創薬標的分子の探索

    2008年 - 2010年

    内藤記念科学振興財団  内藤記念科学奨励金・研究助成 

      詳細を見る

    資金種別:競争的資金

    researchmap

  30. 虚血性網膜血管新生による眼疾患における新規GPCRリガンドapelinの役割

    研究課題/研究課題番号:19890247  2007年 - 2008年

    日本学術振興会  科学研究費助成事業 若手研究(スタートアップ)  若手研究(スタートアップ)

    笠井 淳司

      詳細を見る

    担当区分:研究代表者  資金種別:競争的資金

    配分額:3075000円 ( 直接経費:2670000円 、 間接経費:405000円 )

    糖尿病網膜症などの虚血性網膜症の病態進行に病的な血管新生が深く関与していることが知られている。今回,新規生理活性物質apelinが,虚血性血管新生に関与するのか否かを検討した。その結果,マウス虚血性網膜症(ROP)モデルの網膜において, apelin発現が劇的に上昇していることを明らかにした。また, apelin遺伝子欠損マウスを用いたROPモデルにおいて,野生型マウスと比較して有意に網膜血管量が低下していた。これらの結果から,内因性apelinは,病的な虚血性血管新生に対し,促進的に作用する因子であることを明らかにした。

    researchmap

▼全件表示